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This research was conducted to investigate the in vitro anti-oxidative and anti-diabetic effects of 
medicinal plants, used by traditional healers in Mrewa, Zimbabwe to treat diabetes mellitus and 
these plants include Albizia antunesiana, Cissus cornifolia and Courbonia glauca. These plants 
were reported by traditional healers to possess therapeutical properties among them antidiabetic 
potential with less side effects and low toxicity hence candidates for production of safe phyto-
formulations in the fight against diabetes mellitus.  
The study was focused on type 2 diabetes mellitus due to its high prevalence such as 90- 95% of 
all diabetic cases. Since oxidative stress and hyperglycemia have been reported to be key players 
in the pathogenesis of type 2 diabetes, the main objectives of this study was to evaluate the 
antioxidative, antihypergycemic and cytotoxic effects of natural products from these plant 
extracts in vitro.  
Plant parts (mainly root and leaf) were extracted in ethanol and distilled water after defatting 
with hexane. A number of models have been used to assay the antioxidant power of the different 





 ), DPPH, hydroxyl radical and nitric oxide reducing ability)  revealed that all the 
different parts of all plants extracts do possess antioxidant potential in concentration dependent 
manner to varying extent. However, all the ethanolic root extracts were consistently shown to 
have exceptionally high antioxidant ability with high phenolics content. However, the 
antioxidant activity differs from plant to plant in the following order: Albizia antunesiana, Cissus 
cornifolia and Courbonia glauca (from most active to the least active in that order).  
Furthermore, the effects of plants extracts on carbohydrate hydrolyzing enzyme (α-amylase and 
α-glucosidase) inhibitions were carried out and Albizia antunesiana, Cissus cornifolia and 
Courbonia glauca extracts were shown to possess better α-amylase and α-glucosidase inhibition 
activities compared to acarbose, a standard drug used for the treatment of diabetes.  
In order to ascertain the safety of the extracts, the cytotoxic activities of Albizia antunesiana, 
Cissus cornifolia and Courbonia glauca extracts were investigated on human embryonic kidney 
cells (HEK293). The same trend was observed in all three plants viz the ethanolic extracts were 
XIX 
 
significantly less toxic compared with the aqueous extract and Albizia antunesiana ethanolic root 
extract was the least toxic on the list. Finally, GC/MS analysis was performed to identify the 
phytochemicals present in the extracts and reviewed the presence of phenolics, coumarins, 
tripernoids compounds. Compounds with better ability of quenching free radicals (which possess 
more free hydroxyl groups), such as amyrin and benzene triol were found in the most active 
extract(s). Better radical scavengers were found to be Albizia antunesiana followed by Cissus 
cornifolia then Courbonia glauca ethanol root extracts. The identified phenolic compounds 
possess the ability to donate hydrogen radical or an electron to quench or resultantly neutralize 












However, in vitro results alone without in vivo test are not enough to give insight about the 
activity possessed by a particular plant extract. So for the total confirmation of the 
pharmacological effectiveness of these plant extracts, the in vivo tests are required.  
Nonetheless, the data presented in this thesis give insight on the value of Albizia antunesiana, 
Cissus cornifolia and Courbonia glauca in medicine. This will also mark these plants as 
potential sources for antioxidant and anti-hypergycemic compounds. The knowledge obtained 
from this study could be used to lay foundation for further studies on these plants and their 
extracts and this information will contribute to the field of drug discovery through synthesis of 



























The global health burden of diabetes mellitus have recently evolved into modern day epidemic 
and is precisely recognized as a global public health issue which poses major health and 
socioeconomic challenges (Mbanya et al., 2010). Diabetes mellitus (DM) has turned out to be 
one of the worst killer disease globally, it’s being projected to be the 7
th
 worst killer diseases by 
2030 (WHO, 2011). According to International Diabetes Federation (IDF) (IDF Atlas, 5
th
 
edition, 2011), approximately 347 million people were diabetic in the year 2010 and it is being 
projected to reach 552 million by 2030 (Gardner et al., 2011). 
Diabetes mellitus is a progressive metabolic disorder with hyperglycemia at its epicenter in all its 
forms, either due to insulin deficiency or impaired effectiveness of insulin’s action, or to a 
combination of both. The disease is associated with numerous complications which are classified 
into acute, sub-acute and chronic. Acute complications include hypoglycemia, diabetic 
hyperosmolar, ketoacidosis and hyperglycemic non-ketotic syndrome, while sub-acute 
complications are thirst, polyuria, lack of energy, visual blurriness and weight loss (Oyedemi et 
al., 2009; Calabrese et al., 2012). There are various chronic complications of diabetes mellitus 
which include hypertension, neuropathy, nephropathy, retinopathy and diabetic foot ulcers which 
could result in amputation, renal failure, heart complications which are a few of the prominent 
health burdens (Calabrese et al., 2012). 
The last decade has seen a dramatic escalation in the incidence and prevalence of diabetes 
worldwide (Mbanya et al., 2010). This escalation is more predominant in developing countries 
this is as a result of adopting westernized diets that contain higher amount of fats and calories 
compared to conventional diet. Other factors include urbanization and modern technology, 
sedentary lifestyle etc. 
This combination of high calorie diet and less exercise is a recipe for the development of obesity 
which causes insulin resistance, an important pathogenesis of type 2 diabetes (T2D). Impaired 
glucose tolerance eventually occurs if insulin resistance persists, this leads to elevated blood 
glucose level which causes oxidative stress (OS). OS resulting from increased production of 
ROS (or their inadequate removal) plays a key role in the pathogenesis of late diabetic 
complications (Brownlee, 2000 and 2001; Calabrese et al., 2012). Compelling evidence has 
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demonstrated the key role played by hyperglycemia in the initiation and the facilitation of OS 
(Nishikawa et al., 2000; Calabrese et al., 2012). Hyperglycemia initially increases the production 
of intracellular ROS and subsequently through, protein kinase C (PKC), advance glycated 
endproducts (AGE), and sorbitol pathways, later this leads to diabetic complications.  
Combating hyperglycemia and OS will go a long way in the treatment and management of many 
OS mediated disorders including diabetes mellitus. This can be achieved through consuming 
antioxidants and controlling carbohydrate intake from the diet as well as limiting the caloric 
intake by inhibiting primary carbohydrate metabolising enzymes, α-glucosidase and α-amylase. 
The α-glucosidase and α-amylase play a vital role in the regulation of postprandial blood glucose 
concentration in the human body and its inhibitors, which can subdue postprandial 
hyperglycemia, are usually used to prevent or treat T2D (Lebovitz and Harold, 1997). 
To date anti-diabetic drugs which include metformin, sulfonylureas, thiazolidinediones, insulin, 
GLP-agonists, meglitanides, DPP-IV inhibitors and α-glucosidase inhibitors have been used and 
shown significant positive results in the treatment and management of diabetes. However, they 
have also shown a vast array of side effects namely: nausea, diarrhea, heart failure, drug 
resistance, cancer, weight gain, hypoglycemia and so on (ADA, 2013).  
Alternatively, Natural products, due to their unmatched chemical diversity and biological 
relevance, have been widely accepted as potential, high-quality chemical pools for the screening 
of drug candidates. Medicinal plants have been used in primary health care systems, to prevent 
diseases, maintain health or cure ailments from the dawn of civilization with a number of these 
plants have been proven  to possess  various pharmacological activities (Kalemba and Kunicka, 
2003). 
According to surveys conducted in Africa, more than 5400 plants have been found to have over 
16300 uses in medicine and the value of these medicinal plants and their products in the field of 
drug discovery is quite impressive because  a number of clinically active drugs, derived from 
plant products,  have a natural product pharmacophore (Ibrahim et al., 2012). Hence, much 
attention is given on the screening of medicinal plants with potential bioactive phytochemicals. 
This has also been reinforced by the fact that there is an increased concern for the safe and non-
toxic alternative drugs (Aliyu et al., 2012). The shortfalls observed in current conventional drugs 
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has led the scientific community to investigate plants with the main objective being to uncover 
natural compounds which can be used to ameliorate diabetes related complications and non-toxic 
to the patient (Karimi et al., 2012). 
Hence, this study was conducted to investigate the medicinal properties, specifically the 
antidiabetic activity of medicinal plants which are claimed to treat diabetes by the Shona 
speaking people of Mrewa district Zimbabwe. The specific objective was to determine the 
antioxidant, anti-hyperglycemic and cytotoxicity activity of these medicinal plants in vitro.  
1.1 Literature review 
1.1.1 Historical background of diabetes mellitus 
Diabetes was first described in an Egyptian manuscript from c. 1500 BCE referring "too great 
emptying of the urine", the first case to be discussed was believed to be type 1 (Poretsky, 2009; 
Ripoll et al., 2011). Physicians in India at the same time observed that urine from diabetic 
patients attracts ants (termed it “madhumeha” meaning honey urine) (Poretsky, 2009). The term 
"diabetes" or "to pass through" was first used in 230 BCE by the Greek Apollonius of Memphis. 
(Poretsky, 2009). It has been reported that diabetes was rare during the ancient times for example 
during the time of the Roman Empire; according to Galen, only few cases were observed 
(Poretsky, 2009). 
Indian physicians Sushruta and Charaka in 400-500 AD first described T1D and T2D as separate 
conditions, with type 1 associated with youth and type 2 with being overweight (Poretsky, 2009). 
Functional treatment was only able to be developed during the beginning of the 20
th
 century by 
Canadians Frederick Banting and Charles Best who discovered insulin in early 1921 and 1922. 
The invention of long acting NPH (or neutral protamine Hagedorn) insulin followed in 1940s 
(Baganz et al., 1951; Poretsky, 2009).   
Diabetes mellitus describes a metabolic disorder of multiple aetiology characterised by chronic 
hyperglycemia with disturbances of carbohydrate, fat and protein metabolism resulting from 
defects in insulin secretion, insulin action, or both, due to pancreatic beta cell dysfunction 
accompanied by the bodies progressive insensitivity to insulin which is termed insulin resistance 
(Diabetes care, 2003). It results in biochemical and anatomical structural consequences which 
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have been associated with micro- and macro-vascular complications and morbidity (Levitt, 
2008).  
Diabetes mellitus have been reported to affect all ages, with T1D mellitus starting to manifest 
itself from an early age hence termed juvenile onset diabetes and T2D mellitus previously used 
to start at a later age (adult onset diabetes mellitus). However, due to the dramatic increase of 
type 2 diabetic cases, it has recently been shown to start at juvenile stages (Brownlee, 2001). 
1.1.2 Types of diabetes mellitus 
Based on the etiological classification, diabetes mellitus can be classified into various categories 
namely; Type 1, Type 2, Gestational diabetes and some other forms of diabetes (WHO, 2011). 
However, out of all the subgroups, type 1 and 2 are the most prevalent with type 2 accounting for 
approximately 90-95% percent of total diabetes cases whereas type 1 is approximately 5-10%. 
 Type 1 diabetes mellitus 
Type 1 diabetes (T1D) (formerly called juvenile-onset or insulin-dependent diabetes), accounts 
for approximately 5% to 10% of all people with diabetes. This type is characterized by 
hyperglycemia when the body is unable to produce insulin due to the autoimmune destruction of 
pancreatic beta-cells of the islets of Langerhans eventually eliminating insulin production from 
the body and requires daily administration of insulin to control hyperglycemia. Without insulin, 
cells cannot absorb sugar (glucose), which they need to produce energy (US CDC, 2008). 
Currently there is no cure for T1D, so the affected individual will have to solely depend on 
exogenous insulin injection for survival hence it is called insulin dependent diabetes. Unlike 
T2D, people with type 1 diabetes generally are not obese and may have diabetic ketoacidosis 
(DKA) at the initial stage of the disease. The T1D is not preventable with current knowledge 
(WHO, 2011). 
Symptoms of T1D include: excessive excretion of urine (polyuria), thirst (polydipsia), constant 
hunger (polyphagia), weight loss, vision problem and fatigue. These symptoms usually occur 




 Type 2 diabetes mellitus 
Type 2 diabetes (T2D) (formerly called adult-onset or non-insulin-dependent diabetes) can 
develop at any age, but most commonly becomes apparent during adulthood. But the incidence 
of T2D in children is rising. T2D accounts for the vast majority of people with diabetes 
accounting for 90% to 95% (WHO, 1999).  
In contrast to T1D, insulin resistance is the main characteristic of T2D. Insulin resistance refers 
to the body's tissue and cells inability to respond properly to insulin. Resistance develops 
because of many factors, including genetics, obesity, increasing age, and having high blood 
sugar for a long time (US CDC, 2008). In T2D, there is an insufficient insulin production 
accompanied with insulin resistance. In type 2, unlike type 1, patients are not entirely dependent 
on insulin, since they can still produce insulin; however the body will have lost the ability to 
sense and utilise it. The development of T2D is caused by a combination of lifestyle and genetic 
factors (Ripsin, 2009; Risérus, 2009). While some etiological factors such as; diet and obesity, 
can be controlled or managed while others, such as increasing age, genders, and genetics, are not 
(Ripsin, 2009). Symptoms may be similar to those of T1D, but are often at lesser magnitude. As 
a result, the disease may be diagnosed several years after the onset, once complications have 
already arisen or at an advanced stage. Previously this type of diabetes was seen only in adults 
but now it is also occurring in children (Vijan, 2010).  
Hyperglycemia is a condition when high blood glucose exists in the blood stream and is a 
common feature of uncontrolled diabetes and over time leads to serious damage to many of the 
body's systems, especially the nerves and blood vessels (WHO, 2011). Hyperglycemia have been 
underlined as the main driving forces behind the development T2D associated complications, 
and sustained hyperglycemia eventually results in a condition commonly referred to as OS. The 
OS occurs when there is an increased production of reactive oxygen species (ROS) and 
subsequent decrease in the body’s antioxidant defense mechanism (Kumar et al., 2012). Various 
mechanisms have been reported to lead the destruction of pancreatic β-cells but OS has been 




 Gestational Diabetes Mellitus 
Gestational diabetes (or gestational diabetes mellitus, GDM) is a condition when women who 
have previously never been diagnosed with diabetes exhibit high blood glucose levels during 
pregnancy. Gestational diabetes is at present affecting approximately 3-10% of pregnant women, 
however it depends on the population studied (ADA, 2013). 
This is possibly a pregnancy-related aspect such as the presence of human placental lactogen that 
interferes with susceptible insulin receptors. The exact mechanisms underlying the cause of 
GDM are still elusive (WHO, 2011; ADA, 2013).  
The major cause  of GDM has been reported to be increased insulin resistance. During pregnancy 
fluctuations  in hormonal levels and other causes are thought to obstruct the action of insulin. 
The interference possibly occurs at the level of the cell signaling pathway behind the insulin 
receptor (Carr and Gabbe, 1998). Symptoms of gestational diabetes are similar to those of T2D. 
Gestational diabetes is most often diagnosed through prenatal screening, rather than reported 
symptoms (Carr and Gabbe, 1998; WHO, 2011). 
Some second generation oral glycaemic agents such as Glyburide have been shown to be safe in 
the treatment of GDM. The GDM usually disappears after pregnancy but women with GDM and 
their children are at an increased risk of developing T2D later in life. Approximately half of the 
women with a history of GDM develop T2D within five to ten years after delivery (IDF Atlas, 
5th edition, 2011; Carr and Gabbe, 1998). 
 Other forms of diabetes or prediabetes  
There are quite number of other forms of diabetes that exist (WHO, 2011). Other forms of 
diabetes include those caused by or as a result of: 
 Genetic error or  defects of the beta cell, the part of the pancreas that synthesizes 
insulin— these include maturity-onset diabetes of the young (MODY) or neonatal 
diabetes mellitus (NDM) 
 genetic defects in the action of insulin, this will cause the body unable to control blood 
glucose levels, as seen in leprechaunism and the Rabson-Mendenhall syndrome 
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 other diseases of the pancreas or other conditions that results in the damage of the 
pancreas, include pancreatitis and cystic fibrosis 
 excess amounts of certain hormones resulting from some medical conditions—such as 
cortisol in Cushing’s syndrome—that work against the action of insulin 
 medications that reduce insulin action, such as glucocorticoids, or chemicals that destroy 
beta-cells 
 infections, such as congenital rubella and cytomegalovirus 
 rare immune-mediated disorders, such as stiff-man syndrome, an autoimmune disease of 
the central nervous system 
 genetic syndromes associated with diabetes, such as Down syndrome and Prader-Willi 
syndrome 
1.1.3   Type 2 diabetes mellitus and antioxidative stress  
 Oxidative Stress (OS) 
OS is a physiological condition where there is presence of products called free radicals, which 
are oxygen centered free radicals and molecules having an unpaired electron and reactive oxygen 
species (ROS) or oxidants. This can result either from an excess production of ROS or from the 
inactivation of the antioxidants (AO), thus shifting the ROS/AO equilibrium towards stress 
(Ibrahim et al., 2012). 
These molecules originate from normal physiological processes of aerobic organisms and if not 
quenched by a cascade of antioxidant systems, they become deleterious. All aerobic organisms 
require oxygen for energy production in the form of ATP, which is achieved by metabolising 
variety of energy sources like fatty acids, glucose, lactate, ketones, and amino acids via 
producing ATP, NADH and FADH2.  These cofactors donate electrons to the electron transport 
chain which will generate chemical energy in the form of ATP. This process is normally 
terminated by oxygen which is the last electron acceptor. During this stage Dioxygen accepts 
electrons to make it Superoxide anion radical, an unstable ROS. So this makes superoxide radical 
to be the “primary” ROS, it consequently generates “secondary” ROS, either directly or 
indirectly by a variety of enzymes or metal catalyzed processes (Wiernsperger, 2003).  
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Plants and animals have an enzyme called superoxide dismutase (SOD) which catalyses the 
conversion of superoxide to hydrogen peroxide, a weak ROS (Wiernsperger, 2003). Hydrogen 
peroxides cross the membranes and reacts with superoxide by inactivating the enzymes through 
oxidations of their thiol groups. According to Haber-Weiss and Fenton reactions, hydrogen 
peroxide is converted to hydroxyl radicals in the presence of transition metals. Other ROS 
formed in living systems are singlet oxygen and peroxyl radical (ROO•). Singlet oxygen is 
generated in neutrophil by the reaction between hypochlorous acid (HOCl) and hydrogen 
peroxide. Peroxyl radical is generated from the reaction between hydroxyl radical and singlet 
oxygen with organic molecule like lipid. 
 
 Normal functions of ROS in physiological system  
The body requires minute quantity of ROS to facilitate its normal physiological processes like 
gene expression, cellular growth and defense against infection and to also act as the stimulating 
agents for biochemical processes within the cell (Wiernsperger, 2003). They affect this through 
oxidation of transcription factors such as nuclear factor-kappa B (NF-kB) and activator protein-1 
(AP-1) active sites, leading to gene expression which results in cell growth and development. 
ROS are involved in normal function of the immune system (T cell differentiation, kill pathogens 
and apoptosis), development (cell growth and proliferation, fusion of sperm and growth, 
synthesis of thyroxine) and activation of signal transduction pathways if present in normal 
concentrations. 
 
 Overproduction of ROS 
If ROS is in excess (high concentration), it becomes deleterious by compromising a vast array of 
biochemical pathways and by doing so it promotes the damage to macromolecules such as 
nucleic acids (DNA), lipids, proteins and might have an active role in the pathophysiology of 
several diseases (Wiernsperger, 2003). 
Cell membranes are more vulnerable to ROS damage due to their high concentration of lipids 
and damage to lipids is referred to as lipid peroxidation, this damage occur as multiple stage 
process which eventually leads to cross linking of membrane proteins, change in membrane 
fluidity and formation of lipid-protein, lipid-DNA adduct which may be detrimental to the 
functioning of the cell (Markesbery, 1997; Halliwell, 2000; Zhang et al., 2006) 
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On the other hand, proteins form the main pool of cell constituents and ROS inflict damage to 
proteins through a range of reactions which causes oxidation and change their tertiary structure 
leading to proteolytic degradation, protein-protein cross linkages and fragmentation resulting in 
the loss of the biological activities and decreased cellular functions such as energy production 
(Cabiscol et al., 2000). ROS interact with DNA molecules altering its structure and function 
through modification of DNA bases, single and double strand DNA breaks, loss of purines 
(apurinic sites), damage to the deoxyribose sugar, DNA-protein cross-linkage and damage to the 
DNA repair system. These have a detrimental effect of causing cell death, mutagenesis, 
carcinogenesis and ageing. 
 
 Antioxidants vs ROS 
Antioxidants are a group of molecules and substances, which inhibit damages induced by the 
oxidants by reacting with ROS and converting them into neutral harmless compounds. All 
aerobic organisms have acquired their own antioxidant defenses system to quench the excess free 
radicals, however when OS is prevailing exogenous antioxidant supplementation becomes 
unavoidable (Wiernsperger, 2003; Zhang et al., 2006). The ROS are continuously generated 
from various biochemical processes which lead, to accumulation of these compounds in excess 
amounts, in the body overtime, hence cell have evolved an antioxidant system to keep the 
concentration of ROS in check. This is through antioxidant defenses and repair mechanisms. 
There are various defense mechanisms present in the body, however the one which acts directly 
by removing the oxidant are considered much more effective and offer maximum protection to 
cells. Three mechanisms have been proposed that antioxidants normally operate; i) preventing: 
keeping ROS at a minimum concentration possible, ii) interception: quenching and scavenging 
reactive species either by using catalytic and noncatalytic molecules and (c) repair: repairing 
damaged target molecules (Helmut, 1997) 
 
 Antioxidant defense systems 
Antioxidant defense systems operate in two main forms, the enzyme mediated and the non-
enzyme mediated antioxidant defense. Enzymatic antioxidants present in the body include 
superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx) (Wiernsperger, 2003). 
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SOD protects cells from superoxide toxicity by catalysing the conversion and dismutation of 
superoxide into oxygen and hydrogen peroxide (Wiernsperger, 2003). 
 
Catalase is mostly abundant and located in the peroxisomes, since peroxisomes are involved in 
fatty acid oxidation and hydrogen peroxide is one of the end products of fatty acid peroxidation, 
so catalase prevents the toxic effect caused by hydrogen peroxide to the cell. This is achieved by 
catalysing conversion of hydrogen peroxide to water and molecular oxygen (Wiernsperger, 
2003). GPx is selenium containing antioxidant enzyme that catalyses the reduction of various 
hydroperoxides in the presence of reduced glutathione (Wiernsperger, 2003).  
Various low molecular weight non-enzymic molecules also act as the body’s antioxidant defense 
line, this include glutathione (GSH), α-tocopherol, ascorbate , bilirubin (Wiernsperger, 2003; 
Kunwar, 2009) and some excretory compounds such as bilirubin from heme, urate from uric acid 
and also a lot of proteins such as lothionein, ceruloplasmin, ferritin, lactoferrin, transferrin, 
metallothionein (Wiernsperger, 2003).  
The body is also equipped with the ability to repair ROS mediated DNA damage. These 
mechanisms are specific to particular damages and they include photoreactivation, base excision 
and nucleotide excision repair (Halliwell and Gutteridge, 1989; Wiernsperger, 2003).  
In order to counteract the effects of OS, in some cases, exogenous antioxidant supplements are 
used to restore the bodys homeostasis state. These supplementations come in form of fruits, 
legumes, vegetables, tea, herbs and wine. Their antioxidant ability is attributed to the presence of 
secondary metabolites but mostly polyphenols are capable of donating a hydrogen radical or an 
electron to quench radicals as the resultant aromatic radicals are able to be stabilized by 
delocalization of the resultant radical on the benzene ring (Wiernsperger, 2003). 
 Synthetic antioxidants 
Apart from the natural antioxidants, there have been a wide range of synthetic antioxidants 
incorporated in cosmetics, pharmaceuticals and food products (Wiernsperger, 2003). These 
include synthetic antioxidative agents, such as butylated hydroxyanisole (BHA), butylated 
hydroxytoluene (BHT), propylgallate (PG), and tertiobutylhydroxytoluene (Kunwar, 2009). 
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Thus, the use of antioxidants to counteract the effects of OS in OS-related chronic metabolic 
disorders is an established protocol. T2D is one of such OS related chronic metabolic disorders. 
In T2D, excessive levels of glucose reaching the mitochondria lead to an overdrive of the 
electron transport chain, resulting in overproduction of superoxide anions normally scavenged by 
mitochondrial SOD. When it fails OS develops and it has been recently proposed that this 
mechanism is responsible for the activation of all major pathways underlying the different 
components of vascular diabetic complications (Wiernsperger, 2003). 
Furthermore, hyperglycemia generates and can induce OS by various mechanisms among them 
is: glycation (increased formation of advanced glycation end products (AGEs), PKC activation, 
sorbitol pathway, activation of the renin–angiotensin system (RAS) and autoxidation of glucose. 
These mechanisms have been reported to be the major contributors of diabetic vascular 
complications (Wiernsperger, 2003; Yamagishi and Imaizumi, 2005), mitochondrial coupling of 
NOS by hyperglycemia has also been implicated to be a major contributor of development of OS 
(Brodsky et al., 2002). 
 Autoxidation of glucose       
Autoxidation of glucose is one potential source of oxygen-derived free radicals (OFRs) in 
diabetes, autoxidation of glucose and other monosaccharides is a process which involves chain 
reactions catalysed by transition metals in the presence of excess glucose, eventually it leads to 
the production of free radicals also called reactive oxygen species (ROS) (Wiernsperger, 2003; 
Brodsky et al., 2002; Zhang et al., 2006). Mono saccharides can enolize and thereby reduce 
molecular oxygen under physiological conditions, yielding-ketoaldehydes, H2O2 and free radical 
intermediates which upsets the ROS production and their subsequent elimination by the body’s 
antioxidant system leading to OS (Simon and Rodgers, 1987). The continuous occurrence of this 
process contribute to elevated levels of peroxides and oxides and if unquenched by a cascade of 
antioxidant system will became deleterious by further promoting existence of OS. Glucose can 
oxidize and generates ROS, hydrogen peroxide, and reactive ketoaldehydes. These later 
compounds largely participate in the synthesis of glycated proteins, which are themselves a 




 Glycation          
It is basically a non-enzymatic reaction of reducing sugars and amino groups of proteins, lipids 
and nucleic acids which causes aging of macromolecules; this process has been known to be 
accelerated at an alarming rate under hyperglycemic and/or OS conditions (Yamagishi et al., 
2012). 
According to Dyer et al. (1991), Stern et al. (2002), and Takeuchi and Yamagishi (2008), excess 
reducing sugars (glucose) under hyperglycemic conditions reacts non-enzymically with proteins 
to form compounds and molecules called Amadori products which undergo further 
rearrangements overtime to form cross-linked irreversible senescent macro protein derivatives 
called Advanced Glycated End products (AGEs). 
Formation of AGEs under diabetic condition is accelerated at an alarming rate, these AGEs have 
been implicated in the development of OS through their reaction with Receptors of Advanced 
Glycated End products (RAGEs) and consequently induce inflammatory and thrombogenic 
reactions, thus playing a significant role in the development and progression of vascular 
complications in diabetes (Yamagishi et al., 2008; Takenaka et al., 2006). Additionally, AGEs 
are reported to promote and up-regulate RAGE expression in numerous cell types and activate of 
transcriptional factor nuclear factor-κB (NF-κB) (Yamagishi et al., 2008).  
Henceforth, it is possible that the AGE–RAGE-induced OS generation additional facilitates the 
creation and buildup of AGEs and subsequent RAGE overexpression in diabetes (Brownlee, 
2001; Yamagishi, 2005).  
1.1.4 Complications of type 2 diabetes mellitus 
 
Diabetes is also associated with a wide range of degenerative late complications involving 
various organs, which progress over many years. Generally, deleterious effects of hyperglycemia 
are classified into macrovascular (coronary artery disease, peripheral arterial disease, and stroke) 




These can be further categorized into three more groups which are acute, sub-acute and chronic 
complications. Acute complications includes hypoglycemia (excessively low blood glucose), 
diabetic ketoacidosis (accumulation and production of keto acids which are deleterious), 
hyperosmolar (severe dehydration due to high blood glucose) and hyperglycemic non-ketotic 
syndrome (Knentz and Nattras, 1991) while sub-acute complications are thirst, polyuria, lack of 
energy, visual blurriness and weight loss (Kumar and Clark, 2002). The chronic complications of 
diabetes mellitus include hypertension (high blood pressure), neuropathy( disease of the nervous 
system), nephropathy(kidney complications), retinopathy (eyes disease which might lead to 
blindness) and diabetic foot ulcers which could result to amputation, renal failure, heart 
complications which are a few of the prominent health burdens.  
 Microvascular complications of diabetes 
Several underlying mechanisms have been suggested to be responsible for the onset and 
development of diabetic microvascular complications namely diabetic retinopathy, nephropathy 
and neuropathy. 
Diabetic retinopathy is thought to be the most prevalent of all known vascular complications and 
the risk of developing retinopathy depends on the duration and severity of hyperglycemia 
(Fowler, 2008). Proposed pathological mechanisms in the development of retinopathy include 
the conversion of glucose into sorbitol in the polyol pathway which has a consequence of 
increasing the osmotic stress, cell are injured by the accumulation of glycoproteins from the 
formation of AGEs.  OS environment have also been thought to facilitate microvascular 
complications through interaction of free radical and different biomolecules (Kunisaki et al., 
1995; Fowler, 2008). 
In diabetic nephropathy, several pathological changes occurs which includes increased 
glomerular basement membrane thickness, micro-aneurysm formation, mesangial nodule 
formation (Kimmelsteil-Wilson bodies), and other changes. The mechanisms responsible for this 




American Diabetes Association (ADA) 2007 recognizes diabetic neuropathy as the “the presence 
of symptoms and/or signs of peripheral nerve dysfunction in people with diabetes after the 
exclusion of other causes” (Fowler, 2008). 
The extend of the injury inflicted to the peripheral nerves due to hyperglycemia is not fully 
understood but is proposed to be directly linked to mechanisms such as accumulation of polyol, 
damage from AGEs, and prolonged OS conditions. In diabetics, peripheral nerve damage has 
been found to occur in various forms, including sensory, focal/multifocal, and autonomic 
neuropathies. More than 80% of amputations have been reported to result from foot ulceration or 
injury, which can result from diabetic neuropathy (Fowler, 2008). 
 Macrovascular complications of diabetes 
According to Fowler (2008), the central theme in macrovascular complications is the process of 
atherosclerosis, which results in accumulation of substances and narrowing of arterial walls 
throughout the body. Atherosclerosis is as a result of chronic inflammation and injury to the 
arterial wall in the peripheral or coronary vascular system which might have originated from 
microvascular damage as a result of prolonged hyperglycemia.  
To counteract the endothelial injury and inflammation, oxidized lipids accumulate followed by 
monocytes which later become phagocytes and macrophages. This attracts T-lymphocytes that 
induce smooth muscles to proliferate and develop into collagen. Besides atheroma formation, 
there is also increased adhesion hyper coagulation of blood cells and various substances during 
T2D. Impaired nitric oxide generation and increased free radical formation in platelets, as well as 
altered calcium regulation, may promote platelet aggregation.  
Diabetes has been reported to increase the risks of developing cardiovascular disease (CVD) 
however the exact underlying mechanism(s) for the development of atherosclerosis is poorly 
understood, nevertheless, scientific evidences have provided a profound link between these two 
diabetes associated complications. This is also supported by the fact that CVD is the primary 
cause of death in diabetics (Laing et al., 2003; Paterson et al., 2007; Fowler, 2008).  
 
1.1.5 Treatment and management of diabetes mellitus 
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Diabetes mellitus is a chronic metabolic disorder, at present there is no known cure apart from 
very specific situations, management is mainly focused on regulating the blood sugar levels as 
close to the normal level as possible ("euglycemia") without causing hypoglycemia. This is 
achieved by following a strict well regulated program over a long time. Alternatively to achieve 
("euglycemia") is through consuming a well regulated diet, exercise, and use of appropriate 
medications consistently.  
The accumulative nature of DM as well as late complications calls for the constant reassessment 
of the effectiveness of the treatment and to check if adjustment of the therapeutical is required 
(Deutschländer et al., 2009). This will result in prohibitive cost and ultimately unavailability of 
drugs and treatment to low income and underprivileged communities particularly in developing 
countries. 
 Diet and exercise in the management and treatment of diabetes mellitus 
 Lifestyle interventions such as proper regulation of diet and exercise have proven to be much 
effective before the onset of diabetes. Some previous studies (Markovic et al., 1998; Maggio and 
Pi-Sunyer, 1998) clearly demonstrated the benefit of a healthy diet, regular exercise, and weight 
loss in individuals already diagnosed with diabetes which include regained insulin sensitivity and 
decrease fasting glucose levels. A combined regiment of a strictly controlled diet and regular 
exercise had been shown to help weight loss and prevent weight regain (Folwer, 2007).  
Furthermore, Colberg et al., (2010) reported that exercises have been regarded to be one of the 
cornerstones in the treatment and management of T2D due to its ability to regulate blood sugar 
levels, with minimal undesired side effects. 
 
 Current conventional drugs for diabetes mellitus 
Currently anti-diabetes drugs are available as generics of oral hypoglycaemic agents (ADA, 
2013). These include; Sulfonylureas, Biguanides, Thiazolidinediones Alpha-glucosidase 
inhibitors, Meglitinides - nateglinide 
 
 
 Insulin Sensitizers  
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This class of oral antidiabetic agents acts by increasing insulin sensitivity of cells and tissues. 
 
 Metformin  
Metformin is a biguanide and an analog of galegine, an alkaloid first reported by French 
diabetologist Jean Sterne, which possesses anti-hyperglycemic properties and originates from the 
French lilac or goat's rue (Galega officinalis), a plant used in folk medicine for several centuries 
(Witters, 2001; Bailey and Day, 2004). Metformin works by suppressing glucose production by 
the liver and now believed to be the most widely prescribed antidiabetic drug in the world 
(Bailey and Day, 2004). Its side effects includes gastrointestinal tract disturbance (nausea, 
diarrhea, vomiting) (Kahn et al., 2006), lactic acidosis (Fimognari et al., 2006) and so on. Other 
biguanides include; Phenformin, Buformin. 
 Thiazolidinediones (Glitaziones) 
This class of drug includes: rosiglitazone, pioglitazone, troglitazone. They work via binding to 
PPARγ, a nuclear regulatory protein that facilitates the transcription of glucose and fat 
metabolism regulating genes. The PPARs acts on peroxysome proliferator responsive elements 
(PPRE), these activates insulin sensitive genes hence increased glucose uptake by cells (EMA, 
2009; FDA, 2011) however they have been reported to cause urinary bladder cancer, and 
macular edema and heart failure (FDA, 2011). 
 Insulin Secretagogues 
These classes of oral antidiabetic agents function by stimulating insulin release from pancreatic β 
cells (Neumiller and Setter, 2006). 
 Sulfonylureas  
This class of drug includes glyburide, glimepiride, and glipizide. They work through stimulating 
insulin release by pancreatic beta cells via inhibiting the K
+
ATP channel (Agabegi and Steven, 
2008).  Sulfonylureas bind to an ATP-dependent K
+ 
(KATP) channel on the cell membrane of 
pancreatic beta cells. This inhibits a tonic, hyperpolarizing efflux of potassium, thus causing the 
electric potential over the membrane to become more positive. This depolarization opens 
voltage-gated Ca
2+
 channels (Neumiller and Setter, 2006).  
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The rise in intracellular calcium leads to increased fusion of insulin granulae with the cell 
membrane, and therefore increased secretion of (pro) insulin. However, the side effects of 
sulfonylureas include: hypoglycaemia, liver and kidney damage, cardiovascular damage, 
abdominal upset, headache and hypersensitivity reactions (Patel et al., 2008) 
 Meglitanides (short-acting insulin secretagogues) 
This class of drugs includes repaglinide, nateglinide. They act by inducing the production of 
insulin by pancreastic beta cells. They act on the similar potassium channels as sulfonylureas, but 
at a different binding site. Closing the potassium channel and the opening of the calcium channel 
will facilitates the secretion of insulin by the pancreatic beta cells (Rendell, 2004). Most insulin 
secretagogues causes hypoglycaemia and weight gain (Agabegi and Steven, 2008; Rendell, 
2004) 
 Alpha glucosidase inhibitors  
This class of drugs includes acarbose (Precose/Glucobay), miglitol (Glyset), and voglibose. 
Alpha-glucosidase inhibitors (AGIs) are classified as diabetic pills than hypoglycaemic agents 
since neither possesses a direct effect on insulin secretion or sensitivity. They act by binding 
competitively to enzymes that degrade complex carbohydrates in intestines, preventing 
metabolism of complex sugars (polysaccharides) into monosaccharides e.g. glucose. Hence, they 
reduce postprandial blood glucose excursions. This will results in the low blood glucose to be 
matched more effectively by an impaired insulin response or sensitivity (Germino, 2011).  
AGI use has been associated with gastrointestinal disturbances (flatulence and bloating) 
(Inzucchi, 1998) 
 Peptide analogs (incretin-based therapies) 
Basically they can be further classified as insulin secretagogues which are glucagon-like peptide-
1 (GLP-1) and gastric inhibitory peptide (glucose-dependent insulinotropic peptide, GIP) and 
they are both deactivated by the enzyme dipeptidyl peptidase-4(DPP-4) (Briones, 2006). They 
interferes with the homeostasis of glucose via stimulating the glucose dependent pancreatic 
insulin secretion by suppressing the secretion of glucagon (glucose dependently), by also 
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delaying gastric emptying, increases satiety, and decreasing food intake (Williams et al., 1996 
and Nauck et al., 1997) 
 GLP-1 Receptor Agonists 
This class of drugs includes Exenatide (Exendin-4/Byetta), Liraglutide (Victoza), Taspoglutide. 
Glucagon-like peptide (GLP) agonists bind to a membrane GLP receptor. As a consequence, 
insulin release from the pancreatic beta cells is increased (Amori et al., 2007). They are alleged 
to cause decrease in gastric motility which results in nausea and thought to be responsible for the 
weight lose observed in patients using this drug. The side effects includes acute pancreatitis, 
renal injury, minor hypoglycemia, and/or nausea (Davidson et al., 2010) 
 
 DPP-4 Inhibitors 
This class of drugs includes vildagliptin (Galvus), sitagliptin (Januvia), saxagliptin (Onglyza), 
linagliptin (Tradjenta), allogliptin, septagliptin. The oral DPP-4 inhibitors function by inhibiting 
the metabolism of GLP-1 and GIP which results in decreasing the half-life and blood levels of 
these endogenous incretins. However, they pose side effects like nasophryngitis, urinary tract 
infection, headache and acute pancreatitis (Amori et al., 2007; Germino, 2011). 
 Amylin analogues 
There is only one analogue of amylin such as pramlintide (Symlin). Amylin or Islet Amyloid 
Polypeptide (IAPP) which is co-secreted with insulin in miniature volumes by the beta cells of 
the pancreas. Amylin plays a crucial role in glycemic regulation through slowing gastric the 
emptying gastric and promoting satiety, thereby decreasing post-prandial spikes in blood glucose 
levels (Higham et al., 2000). Amylin agonist analogues slow gastric emptying and suppress 
glucagon. Side effects include nausea. 
On the contrary, current evidence supports the fact that the available diabetes treatment 
regiments can improve the body’s glucose control through a variety of mechanisms, however all 
the available medication has indicated to have severe side effects varying with individuals. 
Therefore, the scientific community is still burdened with the tasks of further investigating 
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alternative sources, with the ultimate goal of developing compound(s) which will ameliorate 
diabetes related symptoms and/or cure for diabetes without concurrently causing adverse effects.  
Most notably, the OS and hyperglycemia are the central themes in the pathogenesis of diabetes 
mellitus  (Calabrese et al., 2012). Given the rate, at which people are consuming high calorie 
diets, the control or proper management of postprandial hypergygycaemia or blood glucose 
spiking after a meal is mandatory and of the utmost importance in preventing and treating 
diabetes (Kim et al., 2005).  
The most effective way to regulate postprandial plasma glucose concentration is with medication 
in combination with dietary restriction and an exercise program (Goke and Herrmann-Rinke, 
1998). One of such approach involves decreasing the absorption of glucose from the gut; this is 
achieved by inhibiting carbohydrate digesting enzymes (e.g., α-amylase and α-glucosidase) 
(Toeller, 1994; Kim et al., 2005). This will result in the low blood glucose to be matched more 
effectively by an impaired insulin response or sensitivity (Germino, 2011), in diabetic and in 
prediabetes cases.  A range of synthetic conventional alpha glucosidase inhibitors (AGI) exist 
and they include; acarbose (Precose/Glucobay), miglitol (Glyset), voglibose. However, AGI has 
been associated with gastrointestinal disturbances (flatulence and bloating) (Inzucchi, 1998), this 
has prompted the search for alternate AGI from safer and natural sources.  Alpha glucosidase 
inhibitions have been one of the mechanisms of action that several plants and mushrooms were 
reported to possess this activity (Matsuur et al., 2002; Sama et al., 2012). This also points out 
that some medicinal plants may have bioactive compounds which are analogs of drugs such as 
acarbose. 
The direct link which exist between hyperglycemia and OS, necessitate the scientific community 
to search for compounds which can inhibit carbohydrates digesting enzymes and the oxidation of 
oxidizable molecules in a chain reaction and such compounds could consequently be vital in the 
therapy and prevention of diabetic complications (Wright et al., 2006). Unfortunately, although 
conventional α-glucosidase inhibitors and synthetic antioxidative agents, exhibit antidiabetic 
activities, they induce liver damage, carcinogenesis and gastrointenal tract disturbance (Saito et 
al., 2003; Subhasree et al., 2009; Inzucchi, 1998). 
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Therefore, there is a need for the development and utilization of more effective alternative drug 
sources of natural origin (Djeridane et al., 2010). Undesirable effects caused by the use of 
synthetic antidiabetic drugs which include stomach upsets, drug resistance just to name a few, 
prompted many researchers now to focus on compounds of natural origins and mostly from 
plants that demonstrated to have antidiabetic potential with less or no side effects and these 
plants would be good candidates for the production of good phyto-formulations in the fight 
against diabetes mellitus (Shai et al., 2008). 
1.1.6 Plants as alternative source for novel antidiabetic compounds. 
Plants had been used by mankind since time immemorial for foods, cloths and also as a source of 
medicine. A lot of derivatives with plants origin are well documented dating back to centuries 
worldwide. African traditional medicine is regarded the most aged and the most varied of all 
traditional medicinal systems (Van Wyk, 2008). 
Given that Africa, specifically southern Africa do possess quite a rich diversity of plants; with 
statistics pointing out that approximately about 25% of the world’s higher plants are found in the 
Sub-Saharan Africa (Van Wyk, 2008). Furthermore, it’s a well-known fact that usage of plants 
for medicinal purpose is a practice which dated back to ancient times, especially in the African 
society. Van Wyk (2008) also reported that in Africa, there are approximately more than 5000 
medicinal plants that had been reported to have over 16,300 medicinal uses.  
This practice remains to be existent in the developing nations and it is on this foundation that 
researchers keep on working on medicinal plants in order to produce/develop the best medicines 
for physiological uses (Musa et al., 2011). Due to these concerns, in recent years,  many studies 
are aimed in searching for alternative safer medication for example the screening of medicinal 
plants and plant products for pharmacologically active compounds. 
Patel (2012) reported that a lot of plants and herbs have been used by many cultures as dietary 
adjuvant to treat a number of ailments without actual knowledge of activity and constituents 
present in them. Recently, there has been a rise in adoption and recommendation of medicinal 
foods, even when their biologically active compounds are unknown, due to their availability, 
safety and effectiveness (Patel, 2012; Dewanjee et al., 2009).  
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This has prompted World Health Organization (WHO) to encourage the intensive investigation 
and screening of traditional plant treatments for diabetes and those that show impressive 
antidiabetic activity with minimal or no side effects are to be considered as excellent candidates 
for alternative oral antidiabetic therapy (Patel, 2012).  
According to WHO 2011, 70-95% of the world’s population, particularly from developing 
countries, rely heavily on plant-derived medicines for their healthcare, in some worst cases 
traditional medicine is not only approved and popular but it is the only healthcare system 
available in remote areas (Mabona and Van Vuuren, 2013).  
In Zimbabwe, it is reported that approximately 5000 plant species are known and more than 500 
(~10%) of them have known medicinal values (Maroyi, 2013).  A research conducted by Maroyi 
(2013) indicated that the knowledge of the importance of medicinal plants is enormous. Fakim 
(2006) reported that traditional healers and herbalists do not possess the knowledge to explain 
the mechanism of actions of their medicine and this makes the practice inferior and associated to 
witchcraft.  
 
On the contrary, scientific researchers have a better understanding of how the body functions, 
which put them at a better position to comprehend the healing powers of plants and their 
potential as multi-functional chemical entities for treating complicated health conditions and this 
makes the use of plant-derived medicines becoming much scientifically popular recently.  
Approximately 800 plants have been reported to have anti-diabetic activities which vary from 
alpha glucosidase inhibition, glucose transport interference, insulin secretion stimulation, 
enhancing glucose tolerance and stimulation of insulin sensitivity (Patel, 2012). This mechanism 
of action displayed by different plants has been strongly tied to phytochemicals present in the 
plant extracts; alkaloids, flavonoids, phenolics, glycosides, methylated sugars, polysaccharides, 
saponins to name a few (Patel, 2012).  
 
The use of medicinal plants have been adopted since ancient times to treat a lot of ailments, some 
of the plants and plant derived materials shown impressive potential to influence the discovery of 
some current conventional medicines. Natural products have influence the discovery of new 
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active drugs or analogs which have natural product pharmacophore e.g. metformin an analog of 
galegine which was extracted from plant galega offinalis (Jarald et al., 2008; Patel, 2012). 
Besides glucose lowering effects, a number of plants have been reported to have the ability to 
facilitate beta cell regeneration, antioxidant activity, cholesterol lowering activity and restoration 
of normal glycogen levels. Unfortunately, some reports indicated the presence of some potential 
toxic and carcinogenic (Fennell et al., 2004) agents in some of these plants making them 
unsuitable for therapeutic applications. It is therefore of the utmost important to intensively 
investigate the potential cytotoxic activity in order to validate safety for the continued use of 
medicinal plants. It has been documented that some plants extracts do have bioactivity however 
it is cancelled by their cytotoxicity; hence such scenarios need to be evaluated to assess the 
overall efficacy of the plant extract.  However, in Zimbabwe, the research data on anti-diabetic 
medicinal plants are poorly documented henceforth this study aimed to fill in that gap and 
furthermore reporting on different mechanisms of actions of medicinal plants used for the 
treatment and management of T2D. The plants were mainly collected from the Mrewa district of 
Zimbabwe near to Harare (Fig. 1.1) and mainly investigated the antioxidant, carbohydrate 
digesting enzymes inhibitory and cytotoxic activities of 3 different medicinal plants usually used 











1.1.7 Plants under study 
  Description, brief systematics and geographical extension of the plants under study 
 
Map of Zimbabwe showing Mrewa District 
 
Fig. 1.1 Zimbabwe Province - and District- map, Showing capital Harare in red and Mrewa 
district in green (Central Statistics Zimbabwe, 2012). 
Mrewa is a town in Zimbabwe, which is 75 kilometers north-east of the capital Harare, along the 
Nyamapanda road towards Mozambique border. It is in the province/state/region of 
Mashonaland East with a population of ~195 000, located on coordinates Latitude: 17° 39' 13" S 
and Longitude: 31° 48' 30" E and an altitude of 1 363 m (CSZ, 2012).  
This study was conducted to investigate five medicinal plants used by Shona people of Mrewa 
district in the eastern part of Zimbabwe to treat diabetes. Through personal communications, the 
selected plants were mentioned by at least three or more traditional healers or herbalists to be 
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used to treat amongst other diseases and ailments, diabetic mellitus. All the selected plants were 
from different families and genus and they are: Albizia antunesiana, Cissus cornifolia and 
Courbonia glauca . 
 Albizia antunesiana harms (Fabaceae).      
  
Fig. 1.2 Picture of Albizia antunesisana harms, taken from Cleveland Dam, Mrewa, Zimbabwe. 
Albizia antunesiana Harms (Fabaceae), commonly called purple-leaved albizia, is indigenous to 
Zimbabwe. Locally, it is called ''Muriranyenze'' and ''Umnonjwana'' by the Shona and Ndebele-
speaking Zimbabweans, respectively (Hyde et al., 2013).  It is a small to medium-sized tree with 
pinnated leaves which are subdivided into leaflets and only the young saplings have distinctly 
purple leaves which turns paler underneath when matured (Hyde et al., 2013).  The tree is mostly 
distributed in southern Africa (Angola, Botswana, Namibia, DRC, Tanzania, Malawi, 
Mozambique, Zambia and Zimbabwe). In Zimbabwe, it is distributed countrywide (Drummond, 
1981). Albizia belongs to the Fabaceae or Leguminosae family and encloses 150 species of 
which 48 are found in Africa, 35 in America and 35 in Asia and is a genus commonly known as 
the legume, pea, or bean families, which are a large and economically important family of 
flowering plants (Stevens, 2001).  
Based on a survey contacted in Mrewa and Mutoko districts in Zimbabwe, personal 
communications reviewed that; the leaves and roots of this plant are expansively used by various 
traditional healers, herbalists and general people for curing several metabolic and non-metabolic 
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disorders and diseases such as sore eyes, cuts, ulcers, sore throat, tonsillitis, tuberculosis, 
gonorrhea, diabetes and cardiac problems. Gelfand et al. (1985) also substantiate this claimed 
reporting that this plant is also used by traditional healers in other regions of Zimbabwe to treat 
other ailments such as: cuts, ulcers, sore throat and tonsillitis.  
Randriamampianina et al. (2013) reported that most plants in the genius Albizia contain bioactive 
compounds like; oleanane-type triterpenoid, saponins, furofuran-type lignan glycosides, 
macrocyclic spermine alkaloids, flavonol glycosides (Kang, 2000), phenolic glycosides and 
pyridoxine derivatives known as ginkgotoxins. There haven’t been any scientific reports so far to 
substantiate the traditional use of albizia as an antidiabetic agent. 
 Cissus cornifolia (Baker) Planch (Vitaceae)     
  
Fig. 1.3 Picture of Cissus cornifolia plants, taken from Chivake River, Mrewa, Zimbabwe 
Cissus cornifolia (Baker) Planch (Vitaceae) commonly called the “Ivy grape” is indigenous to 
Zimbabwe. Locally, it is called ‘’Mudzambiringa’’ and ‘’Idebelebe’’ by the Shona and Ndebele-
speaking Zimbabweans respectively. Cissus cornifolia is a species in the genus Cissus which   
have approximately 350 species of woody climber in the grape family (Vitaceae), the plant is an 
annual sub erect herb with height of about 1.5 m from the permanent woody root base. It has a 
cosmopolitan distribution, though the majorities of this family are confined to the tropics.  
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The survey we conducted in Mrewa district in Zimbabwe in 2012 based on personal 
communications with traditional healers and herbalists reviewed that, the plant (Cissus 
cornifolia) has wide array of uses in African traditional medicine amongst them as an 
antidiabetic agent. It was also pointed out that it is used by the Shona speaking people as a 
remedy for gonorrhea when the leaf, bark or root extract taken with native natron while the leaf-
sap is used among the Tanganyika as a sedative in cases of mental derangement. The root-
decoction is also used for malaria, septic tonsil, diabetes, cardiac problems and pharyngitis 
(Burkill, 2000).   
Musa et al. (2008) reported the methanolic leaf extract of C. cornifolia to possess some 
neuropharmacological activity in vivo using mice and this was further supported by the presence 
of alkaloids, flavonoids, stilbenoids, saponins, steroids and tannins. Jimoh et al. (2013) also 
reported the presence of alkaloid, flavonoids, saponins, steroid, terperiods and tannins in 
methanolic leaf extract of C. cornifolia and they also reported its hypogycemic activity on 
normoglycemic rats. Further investigations indicated its ability to lower glucose in alloxan-
induced diabetic rats. Until now, there is no report on the antioxidant, alpha glucosidase 
inhibitory activity and cytotoxicity of aqueous and ethanol extracts of C. cornifolia leaf and root 












 Courbonia glauca (Klotzsch) Gilg & Bened (Capparaceae) 
  
Fig. 1.4 Picture of Courbonia glauca plant, taken from the Malilangwe Wildlife Reserve, 
Mrewa, Zimbabwe  
Courbonia glauca (Klotzsch) Gilg & Bened (Capparaceae) commonly called the Blue bush-
cherry (English) Katunguru (Shona) Muswezu (Tonga: Zimbabwe) Soswe (Tonga: Zimbabwe) 
respectively (Hyde et al., 2013). It is a small, glabrous, glaucous shrub up to 2 m tall but usually 
1 m tall, with spreading branches from ground level or branching somewhat above the base. The 
fruit is said to be edible although some tribes in the Zambezi valley, Zimbabwe consider it 
necessary to cook it and throw away the water before eating. It is mostly distributed in 
Zimbabwe, Democratic Republic of Congo; Kenya; South Africa; Tanzania and Uganda (Wild, 
1960; Hyde et al., 2013) 
According to the verbal communication survey we conducted in Mrewa and Mutoko districts in 
Zimbabwe in 2012. C. glauca was reported to be used to treat a number of disorder namely 
cancer, wound healing, bacterial infections, hypertension and diabetes. However, despite the 
extensive use of these plant parts in traditional medicine, scientific reports on the biological and 
pharmacological actions of this plant are limited. Based on our present knowledge few 
phytochemical investigations have been carried out on C. glauca (Maerua edulis) ethanol and 
aqueous extracts of the leaves and the roots, Luo et al. (2011) reported that n-hexane extract of 
C. glauca to possess six known fatty acid derivatives, including palmitic acid and its methyl 
ester, stearic acid, palmitoleic acid, oleic acid methyl ester and linoleic acid methyl. In view of 
its medicinal uses and the apparent lack of knowledge on its pharmacological properties, the 
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antioxidant, alpha glucosidase inhibitory activities and cytotoxicity profile of this plant was 
investigated in this study. 
1.1.8 Statement of research problem. 
Diabetes is an epidemic that is projected to continue on the rise, prominent to increased 
morbidity and mortality and greater expenditure of healthcare which will result in economies of 
developing countries being overburdened, much of the burden of diabetes mellitus for both 
patients and society comes from the long term complications associated with this disease. The 
worldwide survey reported that the diabetes mellitus (DM) is affecting nearly 10% of the world’s 
population (Siddharth, 2001). The number of adults with diabetes worldwide is predicted to 
almost double over the next 25 years, from approximately 171 million in 2000 to 552 million by 
2030 which is will be a quadruple from 2.8%  to approximately 9.4% respectively(Chaturvedi, 
2007;Gardner et al., 2011). 
In Africa, diabetes mellitus is no longer a rare disease and contemporary investigations of non-
communicable diseases indicated prevalence from 1% to 20% of the population. The 
epidemiology has shifted from high mortality rate diseases such as AIDS, TB etc. to diabetes 
mellitus (IDF, 2011). In Zimbabwe and South Africa, the prevalence is between 4.5% and 6% 
and between 4% and 6% respectively (Deutschländer et al., 2009; Wild et al., 200; IDF, 2011).  
It is estimated that 80% of the affected are not aware of their condition and by the time they 
become aware the disease would have developed into complications which makes treatment even 
difficult (Wild et al., 2004). 
Treatment of these related diseases and complications are far much beyond the reach of most 
developing countries budgets. The frequency of this disorder may increase tremendously on the 
population of developing countries; this is being perpetuated by to the lack of effective and 
affordable interventions of diabetes mellitus (Marx, 2002). 
At present, out of all the currently available treatments for diabetes mellitus, none have proven to 
be highly effective, that is to completely cure the diseases and at the same time without causing 
severe side effects to the patient. The other set back with all available diabetes drug is that they 
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are expensive hence it makes them far beyond the reach of people in the developing countries, 
regardless of the fact that, that’s where the disease is becoming much more prevalent. 
Given the fact that the majority of the population in developing countries strongly rely on plants 
as their primary source of medicine and also in the light of the fact that more than 500 herbal 
medicines have been shown to possess antidiabetic properties both in vitro and in vivo (Honda et 
al., 2011; Ivorra et al., 1989). The scientific community has been therefore obliged to investigate 
intensively into these claims in trying to verify any possibility of the presence of medicinal value 
in most of the commonly used medicinal plants. 
Additionally, medicinal plants have been widely used to treat a wide range of chronic metabolic 
disorders by traditional healers and herbalists especially in Africa (van Wyk, 2008). Compounds 
derived from natural products have immensely contributed to drug discovery process to a 
significant extend.  This is shown by a big number of conventional drugs that are either 
derivative of natural products or are analogues of natural products (Ibrahim et al., 2012). Thus, 
in recent years the screening of medicinal plants with potential antidiabetic properties has 
received considerable attention due to the increasing concern for safe and non-toxic alternative 
drugs (Aliyu et al., 2012).  
Hence, the current study aims to expansively probe the anti-oxidative and antidiabetic activity of 
various solvent extracts of commonly used medicinal plants from the Mrewa district of 
Zimbabwe and with the aim of finding compounds that might be valuable in ameliorating 
diabetic related metabolic disorders as well as validating, in part, the traditional use of this plant 









Taking all the above facts into consideration, we hypothesize that: 
Zimbabwean medicinal plants  namely Albizia antunesiana, Cissus cornifolia and Courbonia 
glauca, which are commonly used for the treatment of diabetes and other ailments do possess 
antioxidants and antidiabetic activity, specific phytochemicals present in these plants are 
responsible for their pharmacological activities and they are relatively nontoxic. 
 Specific aims  
o To evaluate the antioxidant, antidiabetic activity specifically (enzyme inhibiting 
activity) and cytotoxic activity of different plant extracts in vitro. 
 
 Specific Objectives 
o To conduct a mini ethnobotanical survey (personal communication with traditional 
healers in Mrewa district in Zimbabwe) on the medicinal plants used to treat and 
manage diabetes.  
o To extract plant components using different solvent of increasing polarity (hexane 
(defatting agent), ethanol and water). 
o To investigate the antioxidant potential different of plant extracts in vitro using a 
series of antioxidant assays. 
o To evaluate the total phenolic content of aqueous and ethanolic plant extracts. 
o To use GC/MS analysis to identify different phytochemicals present in the plant 
extracts. 
o To assess the in vitro α-amylase and α-glucosidase inhibitory activities of the aqueous 
and ethanol extracts of the leaf and root part of the extracts of the above mentioned 
medicinal plants.  
o To determine the cytotoxicity effect of the aqueous and ethanol extracts of the leaf 
and root part of three (Albizia antunesiana, Cissus cornifolia, Courbonia glauca) 




1.1.10 Experimental design  
In order to achieve the stated aim and objectives, this research was divided into relevant chapters 
below: 
 Chapter 2 
This chapter gives a detailed listing and description of all chemical reagents, equipment and in 
vitro assays used to investigate the above mentioned aim and objectives. 
 Chapter 3 
This chapter will provide detailed in vitro antioxidant activities and also in vitro α-amylase and 
α-glucosidase inhibitory effects and cytotoxicity activity of ethanol and aqueous extracts of 
Albizia antunesiana harms parts.  
 Chapter 4 
This chapter will provide detailed in vitro antioxidant activities and also in vitro α-amylase and 
α-glucosidase inhibitory effects and cytotoxicity activity of ethanol and aqueous extracts of 
Cissus cornifolia parts.  
 Chapter 5 
This chapter will provide detailed in vitro antioxidant activities and also in vitro α-amylase and 
α-glucosidase inhibitory effects and cytotoxicity activity of ethanol and aqueous extracts of 
Courbonia glauca parts.  
 Chapter 6 
This chapter gives a general discussion and also sum up all the previous chapters and put all the 
chapters in perception by linking and comparing the observed trends in each chapter and against 
other chapters. It highlights all significant findings from each and every chapter, drawbacks and 
also recommendations for further studies in the area of antioxidant, antidiabetic and cytotoxicity 




Agabegi D E., Steven S.: “Step-Up to Medicine (Step-Up Series)”. Hagerstwon, MD: Lippincott 
Williams & Wilkins, pg 185 (2008) 
Aliyu A B., Ibrahim M A., Musa A M., Bulus T., Oyewale A  O.: “Phenolics Content and 
Antioxidant Capacity of Extracts and Fractions of Vernonia blumeoides (Asteraceae)”. 
International Journal of Biological Chemistry, 5: 352-359 (2012). 
American diabetes association (ADA) .: “Types 2 diabetes basics”, www.diabetes.org/diabetes-
basics/type-2/ (accessed July  2013). 
American Diabetes Association (ADA) .: Standards of medical care in diabetes 2007 [Position 
Statement]. Diabetes Care, 30:S4–S41 (2007). 
Amori R E., Lau J., Pittas A G.: "Efficacy and safety of incretin therapy in type 2 diabetes: 
systematic review and meta-analysis". Journal of the American Medical Association, 298(2): 
194–206 (2007). 
Bailey C J., Day C.: “Metformin: its botanical background”. Practical Diabetes International, 
21(3):115–7 (2004). 
Baskar  R., Subhasree  B., Laxmi Keerthana R., Lijina Susan  R., Rajasekaran P.: 
“Evaluation of antioxidant potential in selected green leafy vegetables”. Journal of Agricultural 
and Food Chemistry, 115(4):1213–1220 (2009). 
Briones., Bajaj M.: "Exenatide: a GLP-1 receptor agonist as novel therapy for type 2 diabetes 
mellitus". Expert opinion on pharmacotherapy, 7 (8): 1055–64 (2006). 
Brodsky S V., Gao S., Li H., Goligorsky M S.: “Hyperglycemic switch from mitochondrial 
nitric oxide to superoxide production in endothelial cells”. American Journal of Physiology - 
Heart and Circulatory Physiology, 283: H2130-9 (2002). 
Brownlee M.: “Biochemistry and molecular cell biology of diabetic complications”. Nature, 
414: 813–820 (2001). 
Brownlee M.: Negative consequences of glycation. Metabolism, 49:9–13 (2000). 
Burkill, H.M.: The Useful Plants of West Tropical Africa. 2nd Edn. Royal Botanical Garden 
Kew, 293-294 (2000). 
Calabrese V., Cornelius C., Leso V., Trovato-Salinaro A., Ventimiglia B., Cavalloaro M., 
Scuto M., Rizza S., Zanoli L., Neri S., Castellino P.: “Oxidative stress, glutathione status, 
34 
 
sirtuin and cellular stress response in type 2 diabetes”.  Biochimica et Biophysica Acta (BBA) - 
Molecular Basis of Disease, 1822(5):729-36 (2012). 
Cabiscol E., Piulats E., Echave P., Herrero E., Ros J .: “Oxidative stress promotes specific 
protein damage in Saccharomyces cerevisiae”. Journal of Biological Chemistry, 275:27393–
27398 (2000). 
Carr D B., Gabbe S.: “Gestational Diabetes: Detection, Management, and Implications”. 
Journal of Clinical Diabetes, 16(1): 4 (1998). 
Central Statistics Zimbabwe (CSZ).: Zimstat cartography section 2012. (2012), accessed July 
23, 2013. 
Chaturvedi N.: “The burden of diabetes and its complications: Trends and implications for 
intervention.” Journal of  Diabetes Research and Clinical Practice, 76 (Suppl 1):S3-12 (2007).  
Craven P A., Davidson C M., DeRubertis F R.: “Increase in diacylglycerol mass in isolated 
glomeruli by glucose from de novo synthesis of glycerolipids”. Journal of Diabetes, 39(6):667-
74 (1990). 
Colberg S R., Sigal R J., Fernhall B., Regensteiner J G., Blissmer B J., Rubin R R.: 
“Exercise and type 2 diabetes”. The American College of Sports Medicine and the American 
Diabetes Association: joint position statement executive summary. Diabetes Care, 33:2692–2696 
(2010). 
Davidson J A., Brett J., Falahati A., Scott D.: “Mild renal impairment and the efficacy and 
safety of liraglutide”. Journal of Endocrine Practise, 17:345–355 (2010). 
Deutschländer M S., van de Venter M., Roux S., Louw J., Lall N.: “Hypoglycaemic activity 
of four plant extracts traditionally used in South Africa for diabetes”. Journal of 
Ethnopharmacology, 124(3):619-24 (2009). 
Dewanjee S., Das A K., Sahu R., Gangopadhyay M.: “Anti-diabetic activity of Diospyros 
peregrina fruit: effect on hyperglycemia, hyperlipidemia and augmented oxidative stress 
inexperimental type 2 diabetes”. Journal of Food and Chemical Toxicology, 47(10):2679-85 
(2009). 
Djeridane A., Yousfi M., Brunel J. M., Stocker P.: “Isolation and characterization of a new 
steroid derivative as a powerful antioxidant from Cleome Arabica in screening the in vitro 
antioxidant capacity of 18 Algerian medicinal plants”. Journal of Food and Chemical 
Toxicology, 48: 2599-2606 (2010). 
35 
 
Drummond R B.: Common Trees of the Central Watershed Woodlands of Zimbabwe. Natural 
Resources Board, Harare, pg 44 – 45 (1981). 
Dyer D G., Blackledge J A., Thorpe S R., Baynes J W.: “Formation of pentosidine during 
nonenzymatic browning of proteins by glucose. Identification glucose other carbohydrates as 
possible precursors pentosidine vivo”. The Journal of Biological Chemistry, 266 (1991):11654–
11660 (1991). 
European Medicines Agency (EMA), "European Medicines Agency recommends suspension 
of Avandia, Avandamet and Avaglim", www.ema.europa.eu/ema (2009). Accessed on 923 
September 2012). 
Fakim A G.: “Medicinal plants: Traditions of yesterday and drugs of tomorrow”. Molecular 
Aspects of Medicine, 27:1–93 (2006). 
Fennell C W., Fennell K L., Lindsey L J., McGaw S G., Sparg G I., Stafford E E., 
Elgorashi O M., Staden J V.: “Assessing African medicinal plants for efficacy and safety: 
pharmacological screening and toxicology”. Journal of  Ethnopharmacology, 94:205–21(2004). 
Fimognari F L., Pastorelli R., Incalzi R A.: “Phenformin-induced lactic acidosis in an older 
diabetic patient: a recurrent drama (phenformin and lactic acidosis)”. Diabetes Care, 29(4):950–1 
(2006). 
Fowler M J.: “Diabetes Treatment, Part 1: Diet and Exercise”. Journal of Clinical Diabetes, 
25(3):105-109  (2007). 
Fowler M J.: “Microvascular and Macrovascular Complications of Diabetes”. Journal of 
Clinical Diabetes, 26(2):77-82 (2008). 
Gardner G D., Dolores S.: “Greenspan's basic & clinical endocrinology”. (9th ed.). New York: 
McGraw-Hill Medical, Chapter 17 (2011). 
Gelfand M., Mavi S., Drummond R B., Ndemera B.: “The traditional medical practitioner in 
Zimbabwe”. Zimbabwe: Mambo Press, (1985). 
Germino F W.: “Noninsulin Treatment of Type 2 Diabetes Mellitus in Geriatric Patients: A 
Review”. Clinical Therapeutics, 33(12):1868–1882 (2011). 
Goke B., Herrmann-Rinke C.: “The evolving role of alpha-glucosidase inhibitors” Journal of 
Diabetes / Metabolism Reviews, 14:1S31– 8 (1998). 
Halliwell B.: The antioxidant paradox. Lancet, 355:1179–1180 (2000).  
36 
 
Halliwell B., Gutteridge J M C.: Free Radicals in Biology and Medicine Clarendon Press, 
Oxford, pp 96–98 (1989) 
Helmut S .: "Oxidative stress: Oxidants and antioxidants". Journal of  Experimental Physiology 
82(2):291–5(1997). 
Higham C E., Hull R L., Lawrie L., Shennan K I., Morris J F., Birch N P., Docherty K., 
Clark A.: "Processing of synthetic pro-islet amyloid polypeptide (proIAPP) 'amylin' by 
recombinant prohormone convertase enzymes, PC2 and PC3, in vitro". European Journal of 
Biochemistry, 267(16):4998–5004 (2000). 
Honda K., Moto M., Uchida N., He F., Hashizume N.: “Effects of Lactobacillus rhamnosus 
GG on the development of diabetes in mice with genetic type 2 diabetes”. Journal of Japan 
Society of Nutrition and Food Science, 33:39–45 (2011). 
Hyde M A., Wursten B T., Ballings P.: Flora of Zimbabwe: Species information: Albizia 
antunesiana, (2013). Accessed from www.zimbabweflora.co.zw on (12 march, 2013). 
Hyde M A., Wursten B T ., Ballings P.: Flora of Zimbabwe: Checklist: Capparaceae (2013). 
Ibrahim M A., Koorbanally N A., Kiplimo J J., Islam M  S.: “Anti-oxidative activities of the 
various extracts of stem bark root and leaves of Ziziphus mucronata (Rhamnaceae) in vitro”. 
Journal of  Medicinal Plants Research 6(25):4176-4184, (2012). 
International Diabetes Federation (IDF) .: Diabetes Atlas. 5th ed. Brussels, Belgium, 
International Diabetes Federation (2011). 
Inoguchi T., Battan R., Handler E., Sportsman J R., Heath W., King G L.: Preferential 
elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of 
diabetic rats: differential reversibility to glycemic control by islet cell transplantation. 
Proceedings of the National Academy of Sciences USA, 89:11059-63 (1992). 
Inzucchi S E., Maggs D G., Spollett G R.: “Efficacy and metabolic effects of metformin and 
troglitazone in type II diabetes mellitus”. New England Journal of Medicine, 338:867–872 
(1998). 
Ivorra  M  D., Paya M., Villar., A.: “A Review of natural Products and Plants as potential 
antidiabetic drugs”. Journal Ethnopharmacology, 27:243-275 (1989). 
Jarald E., Joshi S.B., Jain D.C.H.: “Diabetes and herbal medicines”. Iranian Journal of 
Pharmacology and Therapeutics, 7(1):97-106 (2008). 
37 
 
Jimoh A., Tanko Y., Mohammed A.: “Modulatory role of methanolic leaf extract of Cissus 
cornifolia on blood glucose levels of normoglycemic wistar rats”. European Journal of 
Experimental Biology, 3(1):22-27 (2013). 
Kahn S E., Haffner S M., Heise M A.: “Glycemic durability of rosiglitazone, metformin, 
orglyburide monotherapy”. New England Journal of Medicine, 355:2427–2443 (2006). 
Kalemba D., Kunicka A.: “Antibacterial and antifungal properties of  essential oils”. 
Current Medicinal Chemistry, 10:813-829 (2003) 
Kang T H., Jeong S J., Kim N Y., Higuchi R., Kim Y C.: “Sedative activity of two flavonol 
glycosides isolated from the flowers of Albizia julibrissin”. Journal of  Ethnopharmacology, 71: 
321–323 (2000). 
Karimi E., Oskoueian E., Hendra R., Oskoueian A., Jaafar H Z E.: “Phenolic compounds 
characterization and biological activities of Citrus aurantium bloom”. Journal of Molecular 
Biology. 17:1203-1218 (2012). 
Kim Y., Jeong K., Wang M., Lee W., Rhee H.: “Inhibitory effect of pine extract on α-
glucosidase activity and postprandial hyperglycemia”. Journal of  Nutrition, 21:756–761 (2005). 
Koehn F E., Carter G T.: “The evolving role of natural products in drug discovery”. Nature 
Reviews Drug Discovery, 4:206–220 (2005). 
Koya D., King G L.: “Protein kinase C activation and the development of diabetic 
complications”. Journal of Diabetes, 47:859–866 (1998). 
Knentz E., Nattrass M.: “Acute metabolic complications of diabetes: diabetic ketoacidosis, 
hyperosmolar non-ketotic hypoglycaemia and lactic acidosis”. In: Pickup J, Williams G (Eds) 
Textbook of Diabetes. Blackwell Publishing, Oxford (2002) 
Kumar P., Clark M.: “Diabetes mellitus and other disorders of metabolism”. In: Clinical 
Medicine. WB Sunders, London (2002). 
Kumar S., Kumar V., Prakash O.: “Antidiabetic and anti-lipemic effects of Cassia siamea 
leaves extract in streptozotocin induced diabetic rats. Asian Pacific Journal Tropical Medicine, 
3(11):871-3 (2010). 
Kunisaki M., Bursell S E., Clermont A C., Ishii H., Ballas L M., Jirousek M R., Umeda F., 
Nawata H., King G L.: “Vitamin E prevents diabetes-induced abnormal retinal blood flow via 




Laing S P., Swerdlow A J., Slater S D., Burden A C., Morris A., Waugh N R., Gatling W., 
Bingley P J., Patterson C C.: “Mortality from heart disease in a cohort of 23,000 patients with 
insulin-treated diabetes”. Journal of Diabetologia, 46:760–765, (2003). 
Lebovitz H E.:  “Alpha-glucosidase inhibitors”. Endocrinology and Metabolism Clinics of 
North America, 26 (3):539-551(1997). 
Levitt N S.: “Diabetes in Africa: epidemiology, management and healthcare challenges”. 
Heart(British Cardiac Society), 94(11):1376-82 (2008). 
Lorenzi M.: “The Polyol Pathway as a Mechanism for Diabetic Retinopathy”. Attractive, 
Elusive, and Resilient Experimental Diabetes Research, 10 pages 61038 Vol (2007). 
Luo X., Pires D., Jose´A., Aı´nsa., Begon˜ a Gracia., Noe´lia Duarte., Mulhovo S., Elsa 
Anes., Maria-Jose´U., Ferreira.: “Antimycobacterial evaluation and preliminary phytochemical 
investigation of selected medicinal plants traditionally used in Mozambique”. Journal of 
Ethnopharmacology, 137:114–120 (2011). 
Mabona A., Van Vuuren S F.: “Southern African medicinal plants used to treat skin diseases”. 
South African Journal of Botany, 87:175–193(2013). 
Maggio C A., Pi-Sunyer F X.: “The prevention and treatment of obesity: application to type 2 
diabetes”. Diabetes Care, 20:1744 -1766 (1977). 
Markesbery W R.: “Oxidative stress hypothesis in Alzheimer's disease”. Free Radical Biology 
and Medicine, 23:134–147 (1997).  
Markovic T P., Jenkins A B., Campbell L V., Furler S M., Kraegen E W., Chisholm D J.: 
“The determinants of glycemic responses to diet restriction and weight loss in obesity and 
NIDDM”. Diabetes Care, 21:687-694 (1998). 
Maroyi A.: “Traditional use of medicinal plants in south-central Zimbabwe: review and 
perspectives”. Journal of Ethnobiology and Ethnomedicine, 9:31 (2013). 
Marx J.: “Unravelling the causes of diabetes”. Science, 296:686-689 (2002). 
Matsuur H., Asakawa C., Kurimoto M., Mizutani J.: "Alpha-glucosidase inhibitor from the 
seeds of balsam pear (Momordica charantia) and the fruit bodies of Grifola frondosa". Journal 
of  Bioscience, Biotechnology, and Biochemistry, 66 (7):1576–8 (2002). 
Mbanya J C., Motala A A., Sobngwi E., Assah F K., Enoru S T.: “Diabetes in sub-Saharan 
Africa”. Lancet, 375(9733):2254-66 (2010).  
39 
 
Musa A M., A H. Yaro H., Usman M G., Magaji M. Habu.: “Phytochemical and Some 
Neuropharmacological Studies on the Methanolic Leaf Extracts of Cissus cornifolia [Vitaceae] 
in Mice. International Journal of Pharmacology, 4:145-148 (2008). 
Musa S M., Fathelrhman E A., Elsheikh A E., Lubna A M N A., Abdel L E M., Sakina M 
Y.: “Ethnobotanical study of medicinal plants in the Blue Nile State, South-eastern Sudan” 
Journal of Medicinal Plants Research 5(17):4287-4297 (2011).Nauck M A., Niedereichholz U., 
Ettler R.: “Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic 
effects in healthy humans”. American Journal of Physiology - Endocrinology and Metabolism, 
273:E981–E98 (1997). 
Neumiller J J., Setter S M.: “Pharmacologic management of the older patient with type 2 
diabetes mellitus”.  American Journal of Geriatric Pharmacotherapy, 7:324–342 (2006). 
Nishikawa T., Edelstein D., Du X L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M.A., 
Beebe D., Oates P J., Hammes H P., Giardino I., Brownlee M.: “Normalizing mitochondrial 
superoxide production blocks three pathways of hyperglycaemic damage”. Nature, 404:787–790 
(2000). 
Nishizuka Y., Konishi H., Tanaka M., Takemura Y., Matsuzaki H., Ono Y., Kikkawa U.: 
“Activation of protein kinase C by tyrosine phosphorylation in response to H2O2”. Proceedings of 
the National Academy of Sciences USA, 94:11233–11237 (1997). 
Oyedemi S O., Bradley G., Afolayan A J.: “Ethnobotanical survey of medicinal plants used for 
the management of diabetes mellitus in Nkonkobe municipality in South Africa”. Journal of 
Medical Research, 3(12):1040-1044 (2009). 
Patel A., MacMahon S., Chalmers J., Neal B, Billot L., Woodward M., Marre M., Cooper 
M., Glasziou P., Grobbee D., Hamet P., Harrap S., Heller S., Liu L., Mancia G., Mogensen 
C E., Pan C., Poulter N., Rodgers A., Williams B., Bompoint S., de Galan B E., Joshi R., 
Travert F.: "Intensive blood glucose control and vascular outcomes in patients with type 2 
diabetes". New England Journal of Medicine, 358(24):2560–72 (2008).  
Patel D K., Kumar R., Laloo D., Hemalatha S.: “Natural medicines from plant source used for 
therapy of diabetes mellitus: An overview of its pharmacological aspects”. Asian Pacific Journal 
of Tropical Disease, 2:239-250 (2012) 
Paterson A D., Rutledge B N., Cleary P A., Lachin J M., Crow R S.: “The effect of intensive 
diabetes treatment on resting heart rate in T1D: the Diabetes Control and Complications 
40 
 
Trial/Epidemiology of Diabetes Interventions and Complications study”.  Diabetes Care, 
30:2107-2112 (2007). 
Poretsky L.: Principles of diabetes mellitus (2nd ed. Ed.). New York: Springer. p3 (2009). 
Randriamampianina L., Offroy A., Mambu L., Randrianarivo R., Rakoto D., Jeannoda V., 
Djediat C., Puiseux Dao S., Edery M .: “Marked toxicity of Albizia bernieri extracts on 
embryo-larval development in the medaka fish (Oryzias latipes)”. Journal of Toxicology, 
15(64):29-35 (2013). 
Rendell M .: "Advances in diabetes for the millennium: drug therapy of type 2 diabetes". 
MedGenMed: Medscape general medicine, 6(3 Suppl):9 (2004). 
Ripoll B C., Leutholtz I.: “Exercise and disease management”, (2nd ed Ed.). Boca Raton: CRC 
Press. p. 25 (2011).  
Ripsin C M., Kang H., Urban R J .: "Management of blood glucose in type 2 diabetes 
mellitus". Journal of American Family Physician, 79 (1):29–36 (2009). 
Risérus U., Willett W C., Hu F B .: "Dietary fats and prevention of type 2 diabetes". Progress 
in Lipid Research 48 (1):44–5 (2009). 
Saito M., Sakagami H., Fujisawa S .: Cytotoxicity and apoptosis induction by BHA and BHT. 
Journal Anti-Cancer Research, 23(6c):4693–4701 (2003). 
Sama K., Murugesan k., Sivaraj K .: ”In vitro alpha amylase and alpha glucosidase inhibition 
activity of crude ethanol extract of Cissus arnottiana”. The Asian Journal of Plant Science and 
Research, 2 (4):550-553(2012). 
Siddharth N S .: “Containing the global epidemic of diabetes”. Journal of Diabetology, 3:11 
(2001). 
Simon P., Wolf F., Dean R T .: “Glucose autoxidation and protein modification :The potential 
role of 'autoxidative glycosylation' in diabetes”. Biochemical Journal, 245:243-250 (1987). 
Singh L W.: “Traditional medicinal plants of Manipur as anti-diabetics”. Journal of Medicinal 
Plant Research, 5(5):677-87 (2011). 
Shai I., Tirosh A., Bitzur R .: “Changes in tryglycerides levels overtime and risk of type 2 
diabetes in young men”. Diabetes Care, 31:2032-7 (2008). 
Shirwaikar A., Rajendran K., Kumar C D .: “In vitro antioxidant studies of Annona squamosa 
Linn leaves”. Indian Journal of Experimental Biology, 42:803 (2004). 
41 
 
Stern D., Yan S D., Yan S F., Schmidt A M .: “Receptor for advanced glycation endproducts: a 
multiligand receptor magnifying cell stress in diverse pathologic settings”.  Advanced Drug 
Delivery Reviews, 54:1615–1625 (2002). 
Stevens P.F.: “Angiosperm Phylogeny” Angiosperm Phylogeny Website (2001). Accessed from 
http://www.mobot.org/MOBOT/research/APweb/(28 September 2013) 
Takenaka K., Yamagishi S., Matsui T., Nakamura K., Imaizumi T .:  “Role of advanced 
glycation end products (AGEs) in thrombogenic abnormalities in diabetes Current Neurovascular 
Research, 3:73–77 (2006). 
Takeuchi M., Yamagishi S .:  “Involvement of toxic AGEs (TAGE) in the pathogenesis of 
diabetic vascular complications and Alzheimer's disease”. Journal of Alzheimers Disease, 
16:845–858 (2009). 
Toeller M .: “α-Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects”. European 
Journal of Clinical Investigation, 24:31–5 (1994). 
US Center for Disease Control and Prevention (US CDC).: “Maps of Trends in Diagnosed 
Diabetes”. CDC’s Division of Diabetes Translation. National Diabetes Surveillance System and 
CDC Division of Media Relations, (404):639-3286 (2008). 
US Food and Drug Administration (FDA) .: “Pioglitazone HCl (marketed as Actos, Actoplus 
Met, and Duetact)” Accessed 16/09/2013 from http://www.fda.gov/Drugs/DrugSafety/ 
van Wyk B E.: “A broad review of commercially important southern African medicinal plants”. 
Journal of Ethnopharmacology, 119:342–355(2008). 
Vijan  S .: "Type 2 diabetes". Annals of internal medicine, 152 (5):269-275 (2010). 
Wild H .: “Field Guide to Trees of Southern Africa: Capparaceae FZ” 1(1):226-227 (1960). 
Accessed from www.zimbabweflora.co.zw on (10 February 2013). 
Wild S G., Roglic A., Green R., King H .: “Global prevalence of diabetes. Estimated for the 
year 2000 and projection for 2030”. Diabetes care, 27:1047-1054 (2004). 
Williams B., Werner J., Holst J J.:“Gastric emptying, glucose responses, and insulin secretion 
after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in 
type 2 (noninsulin-dependent) diabetic patients”. The Journal of Clinical Endocrinology and 
Metabolism, 81:327–332 (1996). 




World Health Organisation (WHO) .: “Obesity: preventing and managing the global 
epidemic”. WHO Technical Report Series 894, pp 256 (2000).  
World Health Organisation (WHO): “Definition, diagnosis and classification of diabetes 
mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus”. Geneva, 
World Health Organization, (WHO/NCD/NCS/99.2) (1999).  
World Health Organisation (WHO) .: “The world medicines situation traditional medicines: 
global situation issues and challenges”. Geneva, World Health Organization, 
(WHO/NCD/NCS/11)  (2011). 
Wright E J., Scism-Bacon J L., Glass L C .: “Oxidative stress in type 2 diabetes:   the role of   
fasting and postprandial glycaemia”. International Journal of Clinical Practice, 60(3):308-314 
(2006). 
Yamagishi S., Imaizumi T .: “Diabetic vascular complications: pathophysiology, biochemical 
basis and potential therapeutic strategy”.  Current Pharmaceutical Design, 11: 2279–2299 (2005). 
Yamagishi S., Nakamura K., Matsui T., Noda Y., Imaizumi T .: “Receptor for advanced 
glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication”. 
Current Pharmaceutical Design, 44(44):487–495 (2008). 
Zhang X Y., Tan L Y., Cao G Y., Wu O., Xu Y., Shen., Zhou D F .: “ Antioxidant enzymes 
and lipid peroxidation in different forms of schizophrenia treated with typical and atypical 






























2.1 Chemicals, reagents, apparatus and equipment 
Garlic acid, acarbose, α-amylase, α-glucosidase, dinitrosalicylic acid, monosodium and disodium 
phosphate, ,ascorbic acid, 1, 1-diphenyl-2-picrylhydrazyl radical (DPPH), 2 deoxy-D-ribose, iron 
chloride, sodium carbonate, trichloroacetic acid, EDTA, 2-deoxy-D-ribose, pNPG(4-
Nitrophenyl-D-glucopyranoside) and potassium ferricyanide were procured from Sigma-Aldrich 
through Capital Lab Supplies, New Germany, South Africa. Griess reagent, sodium hydroxide, 
hydrogen peroxide, dimethyl sulfoxide (DMSO), sodium nitroprusside, thiobarbituric acid 
(TBA), Folin ciocalteau reagent and were purchased from Merck Chemical Company, Durban, 
South Africa. Starch was purchased from Ace associated chemicals enterprises, South Africa.  
 Glassware and plastic ware 
Beakers, conical and volumetric flasks, test tubes, schott bottles, measuring cylinders, cuvettes, 
pipette tips, latex examination gloves, Ziploc bags, Whatmann filter papers (No. 1, 2, 3) 
 Equipment 
Water bath, rotary evaporator (Buchi rotavapor II, Buchi Germany), electronic balance, UV-VIS 
Spectrophotometer (UV mini-1240 shimadzu) (Shimadzu Corporation, Kyoto, Japan), 
Pipettes(epperndoff), pH meter (schott), magnetic stirrer set, Freezer, Fume hood, Test tube rack, 
Timer, electric blender, Spatula, funnels, masking tape, paper foil, mortar and pestle, Freeze 
dryer, Agilent technologies 6890 Series GC coupled with an Agilent 5973 Mass Selective 
Detector and driven by Agilent chemstation software 
2.2 Preliminary ethnobotanical survey  
We conducted a mini preliminary ethnobotanical survey based on personal communications with 
local traditional healers and herbalist. Plants were selected based on the number of times there 
were mentioned for the folkloric treatment of diabetes mellitus. Based on the above mention 
criteria, the most cited five plants were selected these are: Albizia antunesiana, Cissus cornifolia 





 Sample of ethnobotanical survey questionnaire 
AN ETHNOBOTANICAL SURVEY ON MEDICINAL PLANTS USED BY TRADITIONAL 




CHIPITI TALENT (M.SC. STUDENT) 
UNDER THE SUPERVISION OF MD. SHAHIDUL ISLAM 
DESCIPLINE OF BIOCHEMISTRY 
DEPARTMENT OF BIOCHEMISTRY, GENETICS AND MICROBIOLOGY, SCHOOL OF 
LIFE SCIENCES , COLLEGE OF AGRICULTURE, ENGINEERING AND SCIENCE 
UNIVERSITY OF KWAZULU NATAL, DURBAN, SOUTH AFRICA 
A. Details of the traditional healer 
I. First Name; ………………………,     Surname………………………………………… 





IV. Telephone number……………………………………………………………………….. 
V. Cell number………………………………………………………………………………. 
VI. Email address ……………………………………………………………………………. 
B. Declaration/consent statement 
I, (initial(s))……………….., (surname) ………………………………., have agreed to take part 
in this survey by providing relevant information and also help in the physical identification of the 
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plant(s) sample. All the information I will provide will be accurate and to the best of my 
knowledge. 
Signature……………………...;     Date ……………………………………………….. 
C. Details of the proposed plant. 
I. Local/traditional name……………………………………………………………………. 
II. Botanical name……………………………………………………………………………. 
III. Physical description of the plant 
………………………………………………………………………………………………
…………………………………………………………………………………… 
D. Physical sample and or photo, detailed description of the plant. 
  
Physical sample                                                          Photo 
 










III. Which part of the plant is used for 
medicine?...............................................................................................................................
.................................................................................................................................. . 





V. What is the effective dose administered to a patient at a given 
time?.......................................................................................................................................
............................................................................................................................. . 




VII. Are there any side effects known from the use of this medicine, Yes  
                                                                                   No 









X. Besides the above mentioned plant is there any plant you are aware of that is used to treat 












 Plant collection, authentication and preparation 
Plants parts (leaves and roots) of the three plants namely A. antunesiana, C. cornifolia, and C. 
glauca were collected during the period of March 2012- February 2013 from Mrewa, 
Mashonaland East province, Zimbabwe. The plant samples were identified and authenticated by 
the herbarium unit of the Harare Botanical Garden and Herbarium, Harare, Zimbabwe and 
voucher specimens were deposited for A. antunesiana, C. cornifolia, and C. glauca with voucher 
numbers AA31509, CC082 and CG201 respectively. 
 These plant samples (leaves and roots) of the above mentioned plants were immediately washed 
with distilled water, cut into small pieces and shade-dried until constant weight was attained. The 
dried samples were ground to a fine powder using a blender, and stored individually in air-tight 
Ziploc bags and transported to the University of KwaZulu-Natal, Westville campus, Durban, 
South Africa for further analysis. A bilateral contract has been signed between the University of 
KwaZulu-Natal, Durban, South Africa and Harare Botanical Garden and Herbarium, Harare, 
Zimbabwe before transporting these plant samples from Zimbabwe to South Africa 
 Preparation of plant extract 
The powdered plant part materials were subjected to sequential extraction in three solvent in 
order of increasing polarity (hexane, ethanol and water). Hexane was used specifically for 
defatting. Forty grams of the finely powdered plant part sample were separately defatted with 
hexane. The defatted materials were sequentially extracted with ethanol and water by soaking for 
48 hours in 200 ml of the respective solvent. For ethanol extracts, after filtration through 
Whatmann filter paper (No. 1), the ethanol was evaporated under reduced pressure using a rotary 
evaporator (Buchi rotavapor II, Buchi Germany) at 40 
o
C and the remaining ethanol was let to 
evaporate freely at room temperature. Aqueous extracts were dried using a freeze dryer. The 
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solvent extracts in each case was weighed, transferred to microtubes and stored in a refrigerator 
at 4-8 
o
C until required.  
2.3 Estimation of total phenolic content  
The total polyphenol content of each extract was determined (as gallic acid equivalent) according 
to the method described by (McDonald et al., 2001) with slight modifications. Briefly, 200 µl of 
the extract (240 µg/ml) was incubated with 1 ml of ten-fold diluted Folin ciocalteau reagent and 
800 µl of 0.7 M Na2CO3 for 30 min at room temperature. At the end of the incubation, 
absorbance values were determined at 765 nm using Shimadzu UV mini 1240 
Spectrophotometer (Shimadzu Corporation, Kyoto, Japan). All measurements were done in 
triplicate. The concentration of polyphenol was directly proportional to the absorbance of 
sample. 
 2.4 IN VITRO ANTIOXIDANT ASSAYS 
2.4.1 Ferric (Fe
3+
) reducing antioxidant power assay (FRAP) 
 The FRAP method of (Oyaizu, 1986) with slight modifications was used to measure the 
reducing capacity of the extracts. To perform this assay, 1 ml of different extract concentrations 
(15–240 µg/ml) were incubated with 1 ml of 0.2 M sodium phosphate buffer (pH 6.6) and 1% 
potassium ferricyanide at 50 
o
C for 30 min. After 30 min incubation, the reaction mixture was 
acidified with 1 ml of 10 % trichloroacetic acid. Thereafter, 1 ml of the acidified sample of this 
solution was mixed with 1 ml of distilled water and 200 µl of FeCl3 (0.1 %) in another test tube 
and the absorbance was measured at 700 nm in the above-mentioned Spectrophotometer. 
Increased absorbance of the reaction mixture indicates higher reduction capacity of the extracts 
which has been calculated according to the following formula:  
                                  ( )  
                    
                      
        
 
2.4.2 Free radical scavenging activity (DPPH Assay)  
The free radical scavenging activity of the extracts was determined and compared to that of 
ascorbic and gallic acids by using a method described by Tuba and Gulcin, (2008) with slight 
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modifications. In order to perform this assay, a 0.3 mM solution of DPPH was prepared in 
methanol and 500 µl of this solution was added to 1 ml of the extract at different concentrations 
(15–240 µg/ml). These solutions were mixed and incubated in the dark for 30 min at room 
temperature. The absorbance was measured at 517 nm against a blank lacking the scavenger. 
 The scavenging effects of the solvent extracts in the DPPH assay (including hydroxyl and nitric 
oxide radical assay as discussed below) were calculated according to the following equation: 
                    ( )  ( 
     
  
)        
Where:    is absorbance of control and       absorbance of the sample or standard. 
2.4.3 Hydroxyl radical scavenging (HRS) assay (Deoxyribose method)  
The hydroxyl radical scavenging activity was measured by studying the competition between 
deoxyribose and the solvent extracts for hydroxyl radicals generated by the ascorbate–EDTA– 
H2O2 system (Fenton reaction) as described by (Hinnerburg et al, 2006). The assay was 
performed by adding 200 µl of premixed 100 µM FeCl3 ,100 µM EDTA (1:1 v/v) solution, 100 
µl of 10 mM H2O2, 360 µl of 10 mM 2-deoxy-D-ribose, 1 ml of different extract concentrations 
(15–240 µg/ml), 400 µl of 50 mM sodium phosphate buffer (pH 7.4) and 100 µl of 1 mM 
ascorbic acid in sequence. The mixture was incubated at 50 
o
C for 2 h. Thereafter, 1 ml of 2.8 % 
TCA and 1 ml of 1.0 % TBA (in 0.025 M NaOH) were added to each test tube. The samples 
were further incubated in a water bath at 50 
o
C for 30 min to develop the pink chromogen colour. 
The extent of oxidation was estimated from the absorbance of the solution at 532 nm and the 
hydroxyl radical scavenging activity of the extract is reported as a percentage inhibition of 
deoxyribose degradation. 
2.4.4 Nitric oxide (NO) radical scavenging assay 
Sodium nitroprusside in aqueous solution at physiological pH spontaneously generates nitric 
oxide (NO), which interacts with oxygen to produce nitrite ions that can be estimated by using 
Griess reagent. Scavengers of NO compete with oxygen, leading to reduce the production of NO.  
The assay was carried out by incubating 500 µl of 10 mM sodium nitroprusside in phosphate 
buffer (pH 7.4) and 500 µl of different extract concentrations (15-240 µg/ml) at 37 
o
C for 2 h. 
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The reaction mixture was then mixed with 500 µl of Griess reagent.  The absorbance of the 
chromophore formed during the diazotization of nitrite with sulphanilamide and subsequent 
coupling with napthylethylenediamine was read at 546 nm. The percentage inhibition of nitric 
oxide generated was measured in comparison with the absorbance value of a control (sodium 
nitroprusside in phosphate buffer). 
2.4.5 Gas chromatography-mass spectrometric (GC-MS) analysis 
The aqueous and ethanol extracts of the leaf and root samples of the plant were subjected to GC-
MS analysis. The analysis was conducted with an Agilent technologies 6890 Series GC coupled 
with (an Agilent) 5973 Mass Selective detector and driven by Agilent chemstation software. A 
HP-5MS capillary column was used (30 m × 0.25 mm internal diameter, 0.25 μm film 
thickness). The carrier gas was ultra-pure helium at a flow rate of 1.0 ml/min and a linear 
velocity of 37cm/sec. The injector temperature was set at 250 °C. The initial oven temperature 
was at 60 °C which was programmed to increase to 28.0 °C at the rate of 10 °C/min with a hold 
time of 4 min at each increment. Injections of 2 μl were made in splitless mode with a split ratio 
of 20:1. The mass spectrometer was operated in the electron ionization mode at 70 eV and 
electron multiplier voltage at 1859 V. Other MS operating parameters were as follows: ion 
source temperature 230 °C, quadrupole temperature 150 °C, solvent delay 4 min and scan range 
50-700 amu. The compounds were identified by direct comparison of the retention times and 
mass spectral data and fragmentation pattern with those in the National Institute of Standards and 
Technology (NIST) library.  
2.5 CARBOHYDRATE DIGESTING ENZYMES INHIBITION ASSAYS 
2.5.1 α-amylase inhibitory activity of plant extracts 
The α-amylase inhibitory activity of plant extracts was determined according to the method 
described by Shai et al. (2011) with slight modifications. A volume of 250 µL of each extract or 
acarbose at different concentrations (30-240 µg/mL) was incubated with 500 µL of porcine 
pancreatic amylase (2 U/mL) in 100 mM phosphate buffer (pH 6.8) at 37 
o
C for 20 min. A 250 
µL of 1% starch dissolved in 100 mM phosphate buffer (pH 6.8) was then added to the reaction 
mixture and incubated at 37 
o
C for 1 h. Then 1 mL of Dinitrosalicylic acid (DNS) colour reagent 
was then added and boiled for 10 min. The absorbance of the resulting mixture was measured at 
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540 nm and the inhibitory activity was expressed as percentage of a control sample without the 
inhibitors. 
                   ( )  
                    
                      
        
2.5.2 α-glucosidase inhibitory activity of plant extracts  
The α-glucosidase inhibitory activity was determined according to the method described by 
Ademiluyi and Oboh (2013) with slight modifications. Briefly, 250 µL of the compound or 
acarbose at different concentrations (30-240 µg/mL) was incubated with 500 µL of 1.0 U/mL α-
glucosidase solution in 100 mM phosphate buffer (pH 6.8) at 37 
o
C for 15 min. Thereafter, 250 
µL of pNPG solution (5 mM) in 100 mM phosphate buffer (pH 6.8) was added and the mixture 
was further incubated at 37 
o
C for 20 min. The absorbance of the released p-nitrophenol was 
measured at 405 nm and the inhibitory activity was expressed as percentage of a control sample 
without the inhibitors. 
                   ( )  
                    
                      
        
 
2.6 IN VITRO CYTOXICITY STUDIES OF PLANT EXTRACTS ON CELL LINES 
2.6.1 Cytotoxicity activity of plant extracts in vitro on HEK293 kidney cells using MTT 
assay  
Preparation of plant extracts 
Plant extracts were prepared (reconstituted in 10% DMSO), vortexed, filtered  through 
Whatmann filter paper (No. 1)and left for 15 min, before further dilution with the respective 
growth medium) and tested on kidney cells. 
 Cell line maintenance 
Routine cell culture maintenance of the human embryonic kidney cells (HEK293) was done by, 
incubating the cells at 37◦C in a humidified atmosphere supplemented with 5% CO2. Cells were 
replenished with fresh growth medium every 2–3 days, consisting of media (Minimum Essential 




 MTT Cell proliferation assay 
Aqueous and ethanol extracts were tested for in vitro cytotoxicity, using HEK293 kidney cells by 
3-(4, 5 dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay (Mosmann, 1983; 
Page-McCaw et al., 2007). Confluent monolayer culture suspensions of the cells were 
trypsinised and plated into 96 well plates at a seeding density of  2.5 x 10
3
 cells per well and 
incubated for 24 h at 37 
o
C in a 5% CO2 incubator in a culture medium containing 10% FBS. 
Following 24-h incubation and attachment, the cell culture medium was replaced with fresh 
medium. Thereafter, varied concentrations of plant extracts (50–200 µg/mL) were added in 
triplicate to the cells and the plate incubated for 48 h as previously. Two controls, one containing 
only cells and one containing DMSO were also set up. After 48 hrs, all culture media was 
removed from the plates, the cells were washed with PBS, and 100µL of the cell media and 
100µL of MTT solution (5 mg/mL in phosphate buffered saline) was added to each well. The 
plates were then incubated for 4 h at 37 
o
C. Thereafter, 100µL DMSO solution was added to 
each well to stop the reaction and dissolve the insoluble formazan crystals. Absorbance was 
measured at 570 nm using a Mindray MR-96A microplate reader. The assessment of cytotoxicity 
was based on a comparison with untreated cells and expressed as IC50 (the concentration of the 
sample required to inhibit 50% of cell proliferation), calculated from the dose–response curve 
(curve fit–nonlinear regression, four parameter). The values are presented as means of triplicate 
analyses. 
2.7 Statistical Analysis 
All data are presented as the mean ± SD of triplicates determination. Data were analyzed by 
SPSS statistical software (version 19, Windows IBM Inc., USA) using Tukey’s multiple range 
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3.1.1 Preface 
This manuscript has been published in the Acta Poloniae Pharmaceutica, 70(6):1035-1043 
(2013). 
3.1.2 Abstract 
The anti-oxidative activities of the ethanol and aqueous extracts of the leaf and root samples of 
Albizia antunesiana were determined across a series of four in vitro models. The results showed 




), DPPH, hydroxyl and nitric oxide radical 
scavenging abilities. The ethanol root extract had more potent antioxidant power in all the 
experimental models and to possess a higher total phenol content of 216.6 ± 6.7 mg/g. The GC-
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MS analysis of the aqueous and ethanol extracts of the roots and leaves indicated that several 
aromatic phenolic compounds, a coumarin and some common triterpenoids were present in these 
extracts.  Data from this study suggest that the leaves and roots of A.antunesiana possessed anti-
oxidative activities that varied across the solvents.  
Key words: Anti-oxidative, in vitro, Albizia antunesiana, GC-MS 
3.1.3 Introduction 
Oxidative stress is a biochemical anomaly caused by disparity between the absolute overload of 
oxidants from the normal physiological and biochemical pathways and a successive depletion of 
antioxidant components in the body. It is involved in the pathogenesis of a vast number of 
chronic metabolic disorders which include atherosclerosis, ischaemia/reperfusion injury, chronic 
inflammatory diseases, renal failure and diabetes mellitus  (Calabrese and Cornelius, 2012). 
Hence, the devastating effects of oxidative stress in a number of chronic metabolic disorders 
have compelled the scientific community to search for antioxidative compounds which can 
inhibit the oxidation of oxidizable molecules in a chain reaction that could consequently be vital 
in the therapy and prevention of these disorders (Wright et al., 2006). Unfortunately, although 
synthetic antioxidative agents, such as butylated hydroxyanisole (BHA), butylated 
hydroxytoluene (BHT), propylgallate (PG), and tertiobutylhydroxytoluene exhibit potent free 
radical scavenging effects, they induce liver damage and carcinogenesis in laboratory animals 
(Saito et al., 2003; Subhasree et al., 2009; Djeridane et al., 2010). Therefore, there is a need for 
the development and utilization of more effective antioxidants of natural origin (Djeridane et al., 
2010). 
Medicinal plants have been widely used for the treatment of a range of chronic metabolic 
disorders by traditional healers and herbalists especially in developing countries in Africa where 
more than 5400 medicinal plants have been reported to have over 16000 medicinal uses (van 
Wyk, 2008; Ibrahim et al., 2012). Compounds obtained from natural products have influenced 
the field of drug discovery to a greater magnitude.  This is evident in a number of clinically 
active drugs that are either natural products or analogues of natural product (Koehn and Carter, 
2005; Ibrahim et al., 2012). Thus, in recent years the screening of medicinal plants with potential 
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antioxidant properties has received considerable attention due to the increasing concern for safe 
and non-toxic alternative antioxidants (Aliyu et al., 2012). 
A.antunesiana Harms (Fabaceae), commonly called purple-leaved albizia, is indigenous to 
Zimbabwe. Locally, it is called ''Muriranyenze'' and ''Umnonjwana'' by the Shona and Ndebele-
speaking Zimbabweans, respectively. The leaves and roots of this plant are used by traditional 
healers to cure several metabolic and non-metabolic disorders such as sore eyes, cuts, ulcers, 
sore throat, tonsillitis, tuberculosis, gonorrhea, diabetes and cardiac problems (Ndemera et al., 
1985). However, despite the extensive use of these plant parts in traditional medicine, scientific 
reports on the biological and pharmacological actions of this plant are limited.  
  
Fig. 3.1 Picture of A.antunesiana harms. Picture taken from Chivake river Mrewa, Zimbabwe. 
Hence, the current study aims to expansively probe the anti-oxidative effects of various solvent 
extracts of the leaves and root with the aim of finding compounds that might be valuable in 
ameliorating oxidative stress mediated chronic metabolic disorders as well as validating, in part, 
the traditional use of this plant in the treatment and management of a vast array of chronic 
metabolic disorders.   
3.1.4 Materials and methods  
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Please refer to the section 2.1 – 2.4 and 2.7 in pages (43 – 54) for detailed materials and 
methods. 
3.1.5 Results 
Table 3.1: Percentage recovery (g/g) and total phenolics content of various solvent extracts of A. 
antunesiana parts 
Data are presented as mean ± SD values of triplicate determinations. a-cDifferent superscript letters for a given value within a 
column are significantly different from each other (Tukey’s-HSD multiple range post hoc test, P<0.05)  
The percentage recovery (g/g) obtained from various extracts (Table 3.1) collected from the 
plant indicated that the highest recovery was obtained in the aqueous extracts. All extracts were 
found to possess a high total phenolic content. However, the highest total phenolic content was 
recorded in the ethanol extract of the roots (Table 3.1). 
Table 3.2 shows the total reducing power of the ethanol and aqueous extracts of A. antunesiana 




 as indicated by 
the concentration dependent increase in the percentage reducing power. The ethanol extract of 
the root had a significantly (P<0.05) higher total reducing power than other extract.  
Samples % recovery (g/g) Total polyphenol (mg/g GAE) 
Leaves   
EtOH 4.36 134.3 ± 13.5
b
 




Root   
EtOH 1.59 216.6 ± 6.70
c
 













15  30 60 120 240 
Leaves      
EtOH 16.38 ± 1.30
a
 21.19 ± 2.45
a







Aqueous 8.91 ± 3.39
a
 12.62 ± 4.54
a
 14.50 ± 0.88
a
 18.12 ± 5.69
a 
 39.13 ± 1.00
b
 
Root      
EtOH 36.08 ± 1.12
b
 49.47 ± 2.66
b
 50.64 ± 0.45
c
 54.89 ± 2.39
b
 85.76 ± 1.05
b
 
Aqueous 11.46 ± 2.02
a
 21.04 ± 0.20
a
 25.18 ± 0.63
b
 32.71 ± 1.80
b
 49.21 ± 1.10
b
 
Standard      
Ascorbic acid 76.83 ± 4.92
c
 80.24 ± 3.00
c
 90.26 ± 5.51
d
 91.08 ± 5.43
b
 93.60 ± 6.21
b
 
Data are presented as mean ± SD values of triplicate determinations. a-d Different superscript letters for a given value within a 
column are significantly different from each other (Tukey’s-HSD multiple range post hoc test, P<0.05) 
 
Fig. 3.2 shows the DPPH radical scavenging activities of the leaf (A) and root (B) extracts of A. 
antunesiana parts. All the extracts showed an ability to quench DPPH free radicals as indicated 
by the concentration dependent increase in the percentage inhibition. The root extracts had a 







Fig. 3.2: DPPH radical scavenging activity of ethanol and aqueous extracts of the leaves (A) and 
root (B) of A.antunesiana. 
Arex= aqueous root extract and Erex= ethanol root extract; Alex= aqueous leaf extract and Elex= ethanol leaf extract. Data are 
presented as mean ± SD of triplicate determinations. a-cValues with different letters over the bars for a given concentration of 
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Table 3.3: Percentage hydroxyl radical scavenging activity of extracts from the root and leaves 





15 30 60 120 240 
Leaves      
Ethanol 34.96 ± 0.04
d
 51.63 ± 0.05
d




 83.00 ± 2.00
c
 
Aqueous 4.76 ± 1.83
a
  8.90 ± 4.22
a 
 13.09 ± 4.11
a 
 18.42 ± 3.10
a 
 26.87 ± 8.10
a 
 
Root      
Ethanol 22.50 ± 2.33
c 
 29.00 ± 1.94
c 
 40.04 ± 0.53
d 
 56.90 ± 0.40
d 
 63.00 ± 0.50
d 
 
Aqueous 0.80 ± 0.05
a
  2.50 ± 0.92
a
  5.50 ± 3.40
a 
 13.30 ± 0.73
a 
 27.60 ± 0.71
a
  





  17.35 ± 3.10
b 
 21.85 ± 0.10
b
  26.80 ± 0.70
b 
 30.30 ± 1.20
a
  
Gallic acid 32.00 ± 0.60
d 
 35.57 ± 2.30
d 




 40.20 ± 0.20
c
  
Data are presented as mean ± SD values of triplicate determinations. a-dDifferent superscript letters for a given value within a 
column are significantly different from each other (Tukey’s-HSD multiple range post hoc test, P<0.05). 
The results of the HRS assay indicated that all (ethanol and aqueous) extracts could scavenge 
hydroxyl radicals generated by Fenton’s reaction with the ethanol extracts displaying 
significantly higher scavenging abilities compared to the aqueous extracts and the standards used 
(Table 3.3). It is also notable that the ethanol extract of the leaf consistently demonstrated a 











15 30 60 120 240 
Leaves      
Ethanol 49.27 ± 0.80
b 
 49.36 ± 1.50
b 
 55.47 ± 0.40
c
  55.47 ± 0.30
b 
 56.99 ± 0.21
b 
 
Aqueous 16.80 ± 1.20
a 
 28.00 ± 0.90
a 
 33.6 ± 0.70
a
  35.11 ± 0.70
a
  43.51 ± 2.20
a 
 
Root      
Ethanol 28.24 ± 1.60
b
  37.15 ± 1.30
b
  43.66 ± 0.80
c
  46.54 ± 0.70
c 
 58.57 ± 1.10
c 
 
Aqueous 25.44 ± 6.30
b
  36.64 ± 2.70
b 
 39.44 ± 0.70
c
  42.23 ± 0.90
c 
 55.21 ± 0.20
c 
 
Standards      
Ascorbic acid 51.44 ± 0.05
b 
 56.94 ± 0.90
b 
 58.37 ± 1.40
c 
 62.44 ± 0.70
b
  77.22 ± 1.20
c
  
Gallic acid 43.06 ± 9.20
b
  47.36 ± 0.70
b
  49.76 ± 0.70
b 
 59.33 ± 3.20
b 
 64.59 ± 6.20
b
  
Data are presented as mean ± SD values of triplicate determinations. a-cDifferent superscripts letters for a given value within a 
column are significantly different from each other (Tukey’s-HSD multiple range post hoc test, P<0.05) 
 
Table 3.4 presents the NO inhibition activities of ethanol and aqueous extracts of A. antunesiana 
leaves and roots.  All the extracts were found to exhibit NO inhibition activity but the ethanol 
extract of the leaves demonstrated a higher NO inhibition effect than other extracts. Furthermore, 
the ethanol extracts of the leaves and roots possessed lower IC50 values of 20.42 and 15.95 






Table 3.5: IC50 values of various solvent extracts of A. antunesiana parts in different anti-
oxidative models 
IC 50 values in µg/ml 
Samples   DPPH HRS NO   
Leaves    
Ethanol 42.65 ± 2.45
 b
 34.67 ± 8.90
 b
 20.42 ± 3.79
 a
 
Aqueous 45.70 ± 3.22
 b
 6.02 ± 178.98
 a
* 501.18 ± 23.47
 d
 
Root    
Ethanol 7.08 ± 0.57
 a
 97.72 ± 11.22
 d
 15.95 ± 4.76
 a
 
Aqueous 12.58 ± 1.25
 a





Standards    
Ascorbic acid 5.01 ± 0.76
 a
 64.65 ± 7.78
 c
 15.13 ± 3.22
 a
 
Gallic acid 5.62 ± 2.34
a
 6.30 ± 205.67
 e
* 41.68 ± 2.90
 b
 
The * represent the units of these values which are in mg/ml. Data are presented as mean ± SD values of triplicate 
determinations. a-eDifferent superscripts letters for a given value within a column are significantly different from each other 
(Tukey’s-HSD multiple range post hoc test, P<0.05) 
Identified compounds of EtOH and aqueous extracts of different parts of A.antunesiana by GC-
MS, from all extracts of ethanol and aqueous aromatic compounds which were identified are 
presented in Table 3.6. Benzofuran was present in both extracts of the leaf and isomers catechol 
and resorcinol were all present in root extracts of both, much aromatic compounds like 
pyrogallol, alpha and beta amyrin were present in the ethanolic root extract. 
Phenolic compounds identified in the root and leaf extracts of A.antunesiana, the identified 
represented in the Fig. 3.3 which all do possess a free hydroxyl group attached to it which makes 
them ideal antioxidant compounds. 
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Fig. 3.4 is a schematic illustration of a proposed mechanism by which the identified phenolic 
compounds act to neutralise free radicals generate during bodys normal physiological processes 
like aerobic respiration  
Table 3.6: Identified compounds of EtOH and aqueous extracts of different parts of 
A.antunesiana by GC-MS  
Compounds Retention time (min) Molecular 
mass(g/mol) 




Benzofuran                                                                    7.69                   118.13 
Roots   





















Benzofuran                                                                      
  
7.69 118.13 











Catechol 7.75 110.10 
Resorcinol 8.81 110.10 










catechol resorcinol pyrogallol hydroxyquinol  












Fig.  3.4.  Hydrogen radical donation to a reactive radical species and stabilization of the 
resultant radical 
3.1.6 Discussion 
Albizia antunesiana is used by traditional healers and herbalist to treat and manage non 
metabolic chronic disorders in Mrewa district Zimbabwe (personal communication with 
traditional healers). The genus Albizia comprises over 150 species across the world with many 
species being used for medicinal purposes but only a few have been investigated for biological 
activities (Singh et al., 2004). In this study, we determined the complete anti-oxidative profile of 
the ethanol and aqueous extracts from the leaves and roots as a lead in the search for extracts 
with potential compounds that could be useful in alleviating oxidative stress-associated 
complications. Our findings also indicate that some A. antunesiana extracts possess 
exceptionally high anti-oxidative activities, as proven by the in vitro experimental models. 
In the present study, the set of in vitro assays were employed to cover all possible known 
mechanisms by which different antioxidants operate to inhibit oxidative chain reactions since 
there is no single model known to mimic all oxidative pathways. The ferric reducing antioxidant 
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assay (FRAP) which measures the total reducing ability was measured as ferric (Fe
3+)
 to ferrous 
(Fe
2+
) conversion in the presence of the extracts using the protocol of Oyaizu .(1986). This assay 





). The extent to which it promotes this reduction process will indicate how effective the 
extract is as an antioxidant compound. The significantly (P<0.05) higher antioxidant ability 
indicated by the ethanol extract of the root and leaf samples indicate that the phytochemical 
components with high redox potential in these plant parts are more soluble in ethanol than water.  
DPPH is a stable molecule consisting of a nitrogen-centered free radical with characteristic color 
changes from violet to yellow upon reduction by either the process of hydrogen- or electron- 
donation.  The degree of the reduction is reflective of the radical scavenging (antioxidant) power 
of the compound (Hinnerburg et al., 2006). The results of the DPPH assay of the aqueous and 
ethanol extracts of the leaves and roots revealed that virtually all extracts possessed stronger free 
radical scavenging potential compared to gallic and ascorbic acids.  
However, the IC50 values indicated the best free radical scavenger to be ethanol root extracts 
because of the low value of 7.08 µg/mL which is in the same range with that of ascorbic and 
gallic acids. This could further indicate that these extracts contain powerful free radical 
scavenging phytochemicals that might have the potential to inhibit free radical accumulation 
which usually build up in chronic metabolic disorders and therefore could be useful therapeutic 
agents for treating free radical linked pathological conditions.  
The hydroxyl radicals are highly reactive free radicals formed in biological systems and has been 
implicated as a highly damaging species in free radical pathology, capable of damaging almost 
every molecule found in living systems (Ibrahim et al., 2012). The hydroxyl radical can target 
and damage virtually all types of major macromolecules: carbohydrates, nucleic acids 
(mutations), lipids (lipid peroxidation) and amino acids (Pastor et al., 2000). Henceforth, the 
identification of plant extracts which exhibit high hydroxyl radical quenching potential will be 
useful for the prevention of the hydroxyl radical-mediated destruction of biological molecules 
against oxidative stress related diseases.  
The hydroxyl radical scavenging activity was measured as the percentage inhibition power of the 
extract towards hydroxyl radicals generated from the Fenton’s reaction mixture by studying the 
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competition between deoxyribose and the extract for hydroxyl radicals generated from 
Fe
3+
/ascorbate/EDTA/H2O2  systems (Ibrahim et al., 2012). Our results indicated that all extracts 
had a potential to scavenge hydroxyl radicals. However, the ethanol extracts have proven, at least 
under in vitro conditions, to contain better antioxidants for use against diseases where the 
hydroxyl radical upsurge is an important mechanism for pathogenesis.  
Nitric oxide, a chemical intermediary generated by endothelial cells, macrophages, and neurons 
is involved in a variety of physiological processes (Lata and Ahuja, 2003; Ibrahim et al., 2012). 
Excess concentration of nitric oxide is associated with a number of diseases (Ross et al., 1993). 
Oxygen reacts with excess nitric oxide to form nitrite and peroxynitrite ions, which act as free 
radicals. Our present study indicated that all the extracts have a competing power with oxygen to 
react with nitric oxide and thus inhibition of anions to some extent, which varies across different 
extracts. All the extracts did not show much promising nitric oxide scavenging ability as 
compared to other antioxidant activities. This difference can be accounted for by the way in 
which the nitric oxide radicals are generated and the different physical and chemical properties 
of the antioxidants contained in the extracts (Schwarz et al., 2001)). The difference in 




might be influenced by different 
redox potentials and steric properties (Gardner et al., 1998). 
GCMS analysis of the aqueous and ethanol extracts of the leaves and roots were carried out in 
order to identify the presence of aromatic and phenolic compounds capable of having antioxidant 
activity.  Two isomers of benzenediol (catechol and resorcinol) and two isomers of benzenetriol 
(pyrogallol and hydroxyquinol) were identified in the extracts by comparing their MS spectra to 
those of standard spectra from the NIST library.  Catechol, pyrogallol and resorcinol were found 
in the ethanol and aqueous extracts of the roots while pyrogallol and hydroxyquinol were found 
in the aqueous extract of the leaves.  In addition, coumarin was found in the ethanol and aqueous 
extracts of the leaves and α- and β-amyrin, two well know triterpenoid natural products were 
detected in the ethanol extracts of the roots.  Phenolic compounds such as those described here 
(Fig. 3.3) are capable of donating a hydrogen radical or an electron to quench radicals as the 
resultant aromatic radicals are able to be stabilized by delocalization of the resultant radical on 
the benzene ring (Fig. 3.4). 
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Overall, we concluded that the observed antioxidant activity with the EtOH root extract might be 
linked to the high phenolic content which has been shown by the higher activity of this extract. 
The ethanol root extract has indicated remarkably higher activities across in vitro anti-oxidant 
models used, which could prompt more studies to be done in order to identify and purify the 
active compounds and their underlying mechanisms. Furthermore, the results displayed by the 
ethanol root extract are interesting enough to be used in in vivo models.  Interestingly, findings 
from this study also support the use of the root by traditional healers in the Mrewa district as 
medicine. 
3.1.7 Post-script analysis 
A.antunesiana extracts were further subjected to in vitro α-amylase, α-glucosidase inhibitory and 
cytotoxicity assays to further investigate the possible mechanism of antidiabetic action and the 
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3.2.1 Preface:  
This section of the chapter is still under construction into a manuscript but not yet submitted to 
the journal for publication. 
 
3.2.2 Abstract 
Diabetes mellitus is a chronic disease and its incidence is tremendously increasing globally. One 
therapeutical approach is by decreasing postprandial hyperglycemia by retarding glucose 
absorption through inhibiting carbohydrates digesting enzymes. Albizia antunesiana aqueous and 
ethanol extracts were investigated for α-amylase and α-glucosidase inhibitory activity in vitro. 
The results show that ethanol root extract of A.antunesiana had mild α-amylase inhibition 
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activity and strong α-glucosidase inhibition power also supported by IC50 values (30.68 and 4.35 
µg/ml). The aqueous root extract showed mild inhibition of α-glucosidase but non α-amylase 
inhibition power. The ethanolic (leaf and root) extracts shows to be relatively non-toxic at tested 
concentrations on the HEK 293 cell lines as confirmed by the MTT assay. However the aqueous 
extracts (leaf and root) were cytotoxic at concentrations above 50 µg/ml. Data from this study 
suggest that the ethanolic extracts of roots of Albizia antunesiana possessed α-amylase, α-
glucosidase inhibitory activity in vitro and did not cause significant cell death on the tested 
concentrations.  
3.2.3 Introduction 
The prevalence of type 2 diabetes mellitus (T2DM) is increasing at an alarming rate worldwide 
such that it is currently being estimated to be responsible for 90-95% of all diabetes cases (Wild 
et al., 2004). This is as a result of life-style and socioeconomic changes mainly characterized by 
a decrease of physical activity and an increase in high fat intake among other factors (IDF, 
2011). 
 Hyperglycemia is a hall mark of T2DM and plays vital roles in most of the pathogenic features 
of the disease. Hyperglycemia, a condition which prevails when there is decreased insulin 
sensitivity or decreased insulin secretion from pancreatic β-cells, can further inhibit insulin 
secretion from pancreas and reduce insulin-mediated glucose uptake in peripheral tissues 
(Wolffenbuttel and Haeften, 1995; Shaiq et al., 2002). All diabetic complications (nephropathy, 
neuropathy, microangiopathy, macroangiopathy, retinopathy and cataract) are strongly linked to 
hyperglycemia. This calls for improved treatment of hyperglycemia, T2DM-related risk factors 
and the long-term degenerative disorders so as  to dramatically lower the risk of both micro- and 
macrovascular complications. 
An important strategy to control hyperglycemia is through the inhibition of key carbohydrates 
digesting enzymes such as α-amylase and α-glucosidase which is also vital in preventing diabetic 
complications. The inhibitors of these enzymes (α-amylase and α-glucosidase) delays the 
digestion of carbohydrates, thereby prolonging the overall carbohydrate digestion time and 
reduces the rate at which glucose is absorbed from the gut, thereby lowering the postprandial rise 
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in blood glucose. Thus, inhibition of α-amylase and α-glucosidase is a key in the management 
and treatment of T2DM (Shaiq et al., 2002). 
Currently, there are several conventional prescribed α-glucosidase inhibitor drugs which include 
acarbose, voglibose and miglitol; however, there have been shown to have some undesirable 
adverse effects such as flatulence, diarrhea and abdominal pain which were hostile to patients 
(Shaiq et al., 2002). This indicates the urgent need for the development of newer alternatives. A 
better clinical outcome could be derived from specific α-amylase and α-glucosidase inhibitors 
with strong inhibitory activity against the α-amylase and α-glucosidase and not cytotoxic to 
target cells, but still achieved the desired result of delaying postprandial hyperglycemia. An ideal 
compound or drug will be the one that will mildly inhibit α-amylase and strongly inhibiting α-
glucosidase (Krentz and Baile, 2005). 
The use of medicinal plants have been adopted since ancient times to treat a lot of ailments, some 
of the plants and plant derived products have shown impressing potentials such that they 
influence the discovery of some current conventional medicines. Some medicinal plants have 
been shown to possess other mechanisms of action, which includes α-amylase and α-glucosidase 
inhibition activities (Ortiz-Andrade et al., 2007; Shirwaikar et al., 2005). Unfortunately, some 
reports indicated the presence of some potential toxic and carcinogenic (Fennell et al., 2004) 
agents in some of these plants, making them unsuitable for therapeutic applications. It is 
therefore of the utmost important to intensively investigate the potential cytotoxic activity in 
order to validate safety for the continued use of medicinal plants. It has been documented that 
some plants extracts do have bioactivity however it is cancelled by their cytotoxicity; hence such 
scenarios need to be evaluated so as to assess the overall efficacy of the plant extract (Fennell et 
al., 2004). 
Albizia antunesiana Harms (Fabaceae), commonly called purple-leaved albizia, is indigenous to 
Zimbabwe. Locally, it is called ''Muriranyenze'' and ''Umnonjwana'' by the Shona and Ndebele-
speaking Zimbabweans, respectively. The leaves and roots of this plant are used by traditional 
healers to cure several metabolic and non-metabolic disorders such as sore eyes, cuts, ulcers, 
sore throat, tonsillitis, tuberculosis, gonorrhea, diabetes and cardiac problems (Ndemera et al., 
1985). However, despite the extensive use of these plant parts in traditional medicine, scientific 
reports on the biological and pharmacological actions of this plant are limited. In a recent study, 
73 
 
we reported the anti-oxidative activities of the aqueous and ethanol extracts of the leaves and 
root of the plant as well as their possible bioactive compounds (Chipiti et al., 2013). Hence, the 
present study was therefore undertaken to intensively probe the in vitro α-amylase and α-
glucosidase inhibitory effects and cytotoxicity activities of the ethanol and aqueous extracts of 
this plant as potential sources of nontoxic therapeutically anti-diabetic agents which can be of 
use in achieving normoglycaemia.  
3.2.4 Materials and methods  
Please refer to the section 2.1 - 2.2 and 2.5 - 2.7 in pages (43 - 54) for detailed materials and 
methods. 
3.2.5 Results 
Fig 3.5 shows inhibitory activity of A.antunesiana aqueous and ethanol extracts on α-amylase 
(Fig 3.5A) and α-glucosidase (Fig 3.5B).  The result indicates that A.antunesiana ethanol root 
extract is a better α-amylase inhibitor than the standard acarbose. However, aqueous root and 
both leaf extracts do possess inhibition potential which is significantly lower (P<0.05) than that 
of the standard. Fig 3.5B also indicated the ability of root extracts to have better inhibitory 
activity on α-glucosidase than acarbose, however the inhibitory activity was much  pronounced 
in the ethanol root extract because it  had significantly higher (P<0.05) α-glucosidase inhibition 
at all concentrations tested.  
The IC50 values for inhibiting α-glucosidase (4.35 ± 0.56 μg/mL)
 
and α-amylase (30.68 ± 1.09 
μg/mL)
 
of the ethanol root extract of   indicates that the extract is a moderate inhibitor of α-





Fig. 3.5: A and B = α-amylase and α-glucosidase respectively shows inhibitory activity of 
A.antunesiana aqueous and ethanol extracts. Arex= aqueous root extract and Erex= ethanol root extract; Alex= 
aqueous leaf extract and Elex= ethanol leaf extract. Data are presented as mean ± SD values of triplicate determinations. a-
eDifferent superscripts letters for a given value within a column are significantly different from each other (Tukey’s-HSD 
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Table 3.7: IC50 values for α-amylase and α-glucosidase inhibition activity of A.antunesiana 
extracts 
 IC50 values  (µg/mL) 






















 49.86 ± 2.09
 b
 
Acarbose 52.11 ± 0.56
b
 57.18 ± 3.54
c
 
Arex= aqueous root extract and Erex= ethanol root extract; Alex= aqueous leaf extract and Elex= ethanol leaf extract. Data are 
presented as mean ± SD values of triplicate determinations. a-eDifferent superscripts letters for a given value within a column are 
significantly different from each other (Tukey’s-HSD multiple range post hoc test, P<0.05).  
Fig. 3.6 displays the cytotoxicity activity of the A.antunesiana extracts on HEK 293 kidney cell 
lines as confirmed by MTT assay. As indicated in Fig 3.6 A.antunesiana ethanol root extracts did 
not cause any decrease cell viability to significance extent however the aqueous( leaf and root) 
extracts displayed a significant decrease in cell viability across all tested concentrations (50 – 
200 µg/ml), the cell viability was decreasing as the concentration of the extract was increasing. 
This is also consistent with the high IC50 (Table 3.8) value obtained for A.antunesiana ethanol 
root extract (6.14 ± 325.01
 
mg/ml).The aqueous root extract was the most toxic indicated to have 





Fig. 3.6: Cytotoxicity activity A.antunesiana extracts on HEK 293 kidney cells lines as 
confirmed by MTT cell proliferation assay. Arex= aqueous root extract and Erex= ethanol root extract; Alex= 
aqueous leaf extract and Elex= ethanol leaf extract. Data are presented as mean ± SD values of triplicate determinations. a-
cDifferent superscripts letters for a given value within a column are significantly different from each other (Tukey’s-HSD 
multiple range post hoc test, P<0.05).  
Table 3.8: IC50 values for cytotoxicity activity of A.antunesiana extracts on HEK 293 kidney 
cells. 
Name of extract Cytotoxicity IC50 values in (μg/mL) 
Aa elex 306.58 ± 171.22
 d
 * 
Aa alex 223.05 ± 25.40
 c
 
Aa erex 6.14 ± 325.01
 a
 * 
Aa arex 206.71 ± 13.90
 b
 
Arex= aqueous root extract and Erex= ethanol root extract; Alex= aqueous leaf extract and Elex= ethanol leaf extract. The * 
represent the units of these values which are in mg/ml. Data are presented as mean ± SD values of triplicate determinations. a-
dDifferent superscripts letters for a given value within a column are significantly different from each other (Tukey’s-HSD 





































One treatment option for diabetes mellitus is by decreasing postprandial hyperglycemia and this 
could be achieved by delaying the digestion of carbohydrates in the digestive tract through 
inhibiting carbohydrate hydrolysing enzymes (α-amylase and α-glucosidase). By inhibiting these 
key enzymes, minimal amounts of glucose would be absorbed into the blood stream, hence the 
plasma glucose will not spike after a meal (Ferrannini et al., 2004).  
Present study shows that A.antunesiana root extracts moderately inhibited α-amylase and 
significantly inhibited α-glucosidase activity as evidently shown by the IC50 values (Fig. 3.8). 
This mimics an effective T2DM drug model which has to be strong potent inhibitor of intestinal 
α-glucosidases and mildly inhibits pancreatic α-amylase (Krentz and Baile, 2005). This approach 
however has been reported to cause stomach discomfort due to fermentation of undigested 
carbohydrates materials by bacterium in the colon. The main objective of the in vitro α-
glucosidase and in vitro α-amylase inhibitory assays were to provide get more insight in the in 
vitro potential for the potential inhibition of α-glucosidase and α-amylase and to produce a 
stronger biochemical justification for further possibility of in vivo studies on extracts of 
A.antunesiana based on the observed data. 
In a previous study, we found that the A.antunesiana ethanol root extract contains mainly 
phenolic compounds (catechol, pyrogallol and hydroxyquinol and resorcinol), coumarin and 
triterpenoids (α - and β-amyrin) as the major phytochemical components.  Besides having the 
highest antioxidant activity, the ethanol root extract was found to be effective α-glucosidase and 
α-amylase inhibitor at least in this in vitro study which could be linked to the above mentioned 
phenolic compounds. This is because phenolic compounds were reported to be effective α-
glucosidase and α-amylase inhibitors (de Sousa et al., 2004, Hanamura et al., 2005;Thilagam et 
al., 2013). Based on these observations, the observed inhibitory activity of A. antunesiana 
ethanol root extract could be linked due to one or more of the above-mentioned compounds 
present in the extracts. Furthermore, some of the compounds found in this extract such as 
phenolics, coumarin and triterpenoids were reported as being effective inhibitors of α- amylase 
and α-glucosidase in a recent study (Thilagam et al., 2013). Hence, our in vitro data suggest the 
potential anti-diabetic activity of A.antunesiana ethanol root extract via inhibiting two major 
carbohydrate metabolizing enzymes, α-glucosidase and α-amylase. 
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In order to ascertain the safety of the extracts, the cytotoxicity activities of A.antunesiana 
extracts were investigated and we found out that aqueous leaf and aqueous root extracts showed 
a significant cytotoxicity activity as confirmed in Fig. 3.6 by the reduction in cell viability by 
approximately 51 and 53% respectively at 200 µg/ml concentration. However the ethanol root 
extract did not significantly decrease the viability of cells. Therefore, it necessitates the further 
investigation of the aqueous extracts to identify the responsible compounds for the observed 
toxic activity and further assess their chemotherapeutical properties. Also further aiming to 
identify the bioactive compounds of the ethanol root extracts so as to separate them and realise 
the full therapeutic potentials of the bioactive components.  
Based on the results presented in this section, it can be concluded that ethanolic root extract of 
A.antunesiana exerts an inhibitory effect on α-glucosidase and α-amylase and also shows to be 
relatively non-toxic at tested concentrations. Furthermore, the results displayed by the ethanol 
root extract are interesting enough to be used in in vivo models.  The obtained data further agree 
with logic behind the traditional use of plants in medicine based on their inhibitory activity of 
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Running title:  
Anti-oxidative potential of Cissus cornifolia. 
4.1.1 Preface 
This chapter has been accepted for publication in the Acta Poloniae Pharmaceutica recently. 
4.1.2 Abstract 
The study was intended to explore the antioxidant potential and phytochemical content of the 
ethanol and aqueous extracts of the leaf and root samples of Cissus cornifolia (Baker) Splanch 





), and DPPH, hydroxyl and nitric oxide radical scavenging abilities to 
varying extents. However, the ethanol root extract had more potent antioxidant power in all the 
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experimental models than other extracts and possess a higher total phenol content of 136.1± 6.7 
mg/g. The GC-MS analysis of the aqueous and ethanol extracts of the roots indicated the 
presence of the common aromatic phenolic compounds, pyrogallol, resorcinol and catechol, a 
fatty acid, n-hexadecanoic acid and an aldehyde, vanillin.  Data from this study suggest that both 
the leaves and roots of C. cornifolia possessed anti-oxidative activities with the best anti-oxidant 
activity being exhibited by the ethanolic extract of the root. The antioxidant properties of the root 
extracts can be attributed to the phenolic compounds present in the extracts.  
Key words: antioxidant, Cissus cornifolia, in vitro, polyphenols. 
4.1.3 Introduction 
The biochemical state of the body, when there is an imbalance between the production of 
reactive oxygen and a biological system's ability to readily detoxify the reactive intermediates or 
easily repair the resulting damage, is termed oxidative stress (OST). Oxidative stress has been 
implicated in the pathogenesis of a number of diseases such as atherosclerosis, Parkinson’s, heart 
failure, myocardial infarction, Alzheimer's disease, fragile X syndrome, chronic fatigue 
syndrome and diabetes (Calabrese et al., 2012). 
The deleterious effects of oxidative stress in a number of metabolic chronic disorders has 
prompted scientists to search for antioxidative compounds that can impede the oxidation of 
biomolecules in a chain reaction, which could be vital in the therapy and prevention of many 
metabolic disorders (Wright et al., 2006).  The synthetic antioxidative agents, such as butylated 
hydroxyanisole (BHA), butylated hydroxytoluene (BHT), propylgallate (PG), and 
tertiobutylhydroxytoluene exhibit potent free radical scavenging effects but they induce liver and 
kidney dysfunction and have also been reported to be carcinogenic in laboratory animals (Saito 
et al., 2003; Subhasree et al., 2009; Djeridane et al., 2010). Thus, there is a need to identify and 
utilize more antioxidants of natural origin, which can combat the deleterious effects of free 
radicals and other biological oxidants (Djeridane et al., 2010). 
Plants have a long history of use in medicinal applications, especially in Sub-saharan Africa 
where access to medical supplies, pharmaceutics and medical doctors are limited.  The uses of 
these medicinal plants have been well documented over the years and their use, especially in the 
rural areas of African countries is quite popular (van Wyk et al., 2008). Based on this, research 
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activities on medicinal plants, especially on the phytochemistry and bioactivity of medicinal 
plants have been stimulated in order to develop alternative therapies for a number of diseases 
(Musa et al., 2008). Recently the screening of medicinal plants and plant products potential 
antioxidant and antidiabetic has received significant attention due to an increasing fear for unsafe 
drugs (Aliyu et al., 2012). 
Cissus cornifolia (Baker) Splanch (Vitaceae), commonly called the “Ivy grape” is indigenous to 
Zimbabwe.  It is locally called ‘’Mudzambiringa’’ and ‘’Idebelebe’’ by the Shona and Ndebele-
speaking Zimbabweans respectively. Cissus is a genus of approximately 350 species.  Most of 
the members of this genus have a wide array of uses in African traditional medicine (Wild et al., 
1969).  C. cornifolia, commonly found in Zimbabwe, is traditionally used by the Shona speaking 
people as a remedy for gonorrhea while the leaf-sap is used among the Tanganyika as a sedative 
in cases of mental derangement; the root-decoction is also used for malaria, septic tonsil, 
diabetes, cardiac problems and pharyngitis (Burkill, 2000). Currently, there have been no 
phytochemical or biological activity studies on C. cornifolia.  Phytochemical studies on other 
species of Cissus have revealed the presence of glycosides, flavonoids, saponins, steroids, 
terpenoids and tannins (Jimoh et al., 2013; Musa et al., 2011; Jainu et al., 2006; Varadarajan et 
al., 2008).  
Bioactivity and isolation of various compounds have been carried out in a number species from 
the genus Cissus and had shown impressive results. Cissus quadrangularis Linn. Wall. Ex which 
is commonly used as a food supplement in India, was evaluated for its protective effects against 
neutrophils (Jainu et al., 2006). Jainu and Devi (2003) reported that Cissus quadrangularis has 
antimicrobial, antiulcer, antioxidative and cholinergic activity as well as potent fracture healing 
properties and a beneficial effect on cardiovascular diseases. In addition, the same group 
reported cytoprotective properties of the methanolic extract of the same plant (Jainu et al., 2004). 
Attawish et al. (2002) isolated Vitamin C, β-carotene, two asymmetric tetracyclic triterpenoids, 
β-sitosterol, α-amyrin, α-amyrone from Cissus quadrangularis which they accredited to the 
observed activities and Potu et al. (2010) also reported several phytochemical constituents, such 
as ascorbic acid, flavonoids, and triterpenoids in Cissus quadrangularis. 
Cissus sicyoides L, has been widely used in folk medicine against stomachache and indigestion 
(Asprey and Thornton., 1954) and has been reported to treat diabetes, pain, inflammation, 
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rheumatism, abscesses, muscle inflammation, convulsions, epilepsy, stroke and hypertension 
(Ferreira et al., 2008). Ferreira et al. (2008) also reported a coumarin glycoside, coumarin 
sabandin, flavonoids, steroids, sitosterol and hydrolysable tannins from the plant. Cissus 
populnea has been reported as a food supplement in Nigeria (Ibrahim and Dawes, 2000), 
however there are no reports on the phytochemistry of the plant in the literature. Ojekale et al. 
(2007) reported Cissus populnea to have a myriad of uses as a medicinal agent globally. 
    
Fig. 4.1: Picture of Cissus cornifolia plants. Picture taken from Chivake River, Mrewa, 
Zimbabwe 
This study was undertaken to investigate the ethnomedicinal efficacy of the leaf and root ethanol 
and aqueous extracts of the plant as potential sources of therapeutic agents which can be of use 
in ameliorating oxidative stress related parameters using various models in vitro. We also 
subjected the extracts to GC-MS analysis in order to partially explore the phytochemistry of the 
plant. 
 
4.1.4 Materials and Methods  





Table 4.1: Percentage recovery (g/g) and total phenolic content of various solvent extracts of C. 
cornifolia parts 
Data are presented as mean ± SD values of triplicate determinations. a-dDifferent superscript letters for a given value within a 
column are significantly different from each other (Tukey’s-HSD multiple range post hoc test, P<0.05)  
 
The percentage recovery (g/g) obtained from various extracts (Table 4.1) collected from the 
plant indicated that the highest recovery was obtained in the aqueous extracts.  All extracts were 
found to possess a high total phenolic content. However, the highest total phenolic content was 
recorded in the ethanol extract of the roots (136.1 ± 10.6 mg/g GAE) (Table 4.1).   
Table 4.2 shows the total reducing power of the ethanol and aqueous extracts of C. cornifolia 





as indicated by the concentration dependent increase in the percentage reducing power. The 





Samples % Recovery (g/g) Total polyphenol (mg/g GAE) 
Leaves   
EtOH 2.70 52.9 ± 12.5
a
 
Aqueous 5.91 89.9 ± 7.40
b
 
Root   
EtOH 1.69 136.1 ± 10.6
d
 











15  30 60 120 240 
Leaves      
EtOH 9.81 ± 1.30
a
 14.12 ± 2.45
a







Aqueous 4.65 ± 3.39
a
 10.79 ± 4.54
a
 14.51 ± 0.88
a
 29.15 ± 5.69
a 
 30.71 ± 1.00
a
 
Root      
EtOH 29.75 ± 1.12
c
 45.75 ± 2.66
c
 52.80 ± 0.45
d
 75.22 ± 2.39
c
 93.09 ± 1.05
c
 
Aqueous 15.95 ± 2.02
b
 30.18 ± 0.20
b
 40.69 ± 0.63
c
 45.71 ± 1.80
b
 75.51 ± 1.10
b
 
Standard      
Ascorbic acid 76.83 ± 4.92
d
 80.24 ± 3.00
d
 90.26 ± 5.51
e
 91.08 ± 5.43
d
 93.60 ± 6.21
c
 
Data are presented as mean ± SD values of triplicate determinations. a-e Different superscript letters for a given value within a 
column are significantly different from each other (Tukey’s-HSD multiple range post hoc test, P<0.05. 
 
Fig. 4.2 shows the DPPH radical scavenging activities of the leaf (A) and root (B) extracts of 
C.cornifolia parts. All the extracts showed an ability to quench DPPH free radicals as indicated 
by the concentration dependent increase in the percentage inhibition. The root and leaf ethanol 
extracts had a consistently higher DPPH radical scavenging activity, which is concentration 




Fig. 4.2: DPPH radical scavenging activity of ethanol and aqueous extracts of the leaves (A) and 
roots (B) of C. cornifolia. Arex= aqueous root extract and Erex= ethanol root extract; Alex= aqueous leaf extract and 
Elex= ethanol leaf extract. Data are presented as mean ± SD of triplicate determinations. a-cValues with different letters over the 
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The results of the HRS assay indicated that all (ethanol and aqueous) extracts could scavenge 
hydroxyl radicals generated by Fenton’s reaction with the ethanol extracts displaying 
significantly higher scavenging abilities compared to the aqueous extracts and the standards used 
(Table 4.3). It is also notable that the ethanol extract of the root consistently demonstrated a 
significantly higher (P<0.05) HRS activity than all other extracts. 
Table 4.3: Percentage hydroxyl radical scavenging activity of extracts from the root and leaves 




 Concentration (µg/ml) 
15 30 60 120 240 




 55.41 ± 1.3
e
 70.34 ± 0.3
d
 78.57 ± 0.1
d






 27.89 ± 1.2
b
 43.51 ± 4.8
c
 48.63 ± 3.3
c
 54.12 ± 2.2
b
 




 47.40 ± 1.3
d
 64.71 ± 0.2
d
 88.46 ± 2.0
e






 20.42 ± 1.6
a
 32.13  ±  2.0
b
 51.50 ± 0.3
c
 69.90 ± 5.6
c
 





 17.35 ± 3.10
a 
 21.85 ± 0.10
a
 26.80 ± 0.70
a 






 35.57 ± 2.30
c




 40.20 ± 0.20
a
 
Data are presented as mean ± SD values of triplicate determinations. a-eDifferent superscript letters for a given value within a 
column are significantly different from each other (Tukey’s-HSD multiple range post hoc test, P<0.05 
 
Table 4.4 presents the NO inhibition activities of ethanol and aqueous extracts of C.cornifolia 
leaves and roots.  Root extracts (ethanol and aqueous) were found to exhibit better NO inhibition 
activity but the ethanol extract of the root demonstrated a higher NO inhibition effect than other 
extracts. Furthermore, the root extracts possessed lower IC50 values of 24.86 and 36.33 µg/mL 
respectively, than the corresponding leaf extracts in these plant parts (Table 3.5). 
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15 30 60 120 240 




 27.48 ± 1.9
b
 28.24 ± 0.7
b
 43.51 ± 1.4
b




ND 11.19 ± 0.6
a
 12.91 ± 1.0
a
 16.28 ± 0.7
a
 22.95 ± 0.7
a
 




 44.52 ± 0.9
c
 57.58 ± 1.0
c
 83.11 ± 2.2
d






 50.63 ± 1.0
c
 54.7 ± 0.7
c
 63.15 ± 0.1
c
 70.48 ± 0.8
c
 








 62.44 ± 0.70
c






  47.36 ± 0.70
c
 49.76 ± 0.70
c
 59.33 ± 3.20
c
 64.59 ± 6.20
c
  
Data are presented as mean ± SD values of triplicate determinations. a-dDifferent superscript letters for a given value within a 













Table 4.5: IC50 values of various solvent extracts of C. cornifolia parts in different anti-oxidative 
models 
IC 50 values in µg/ml 
Samples   DPPH HRS NO   
Leaves    
Ethanol 11.02 ± 3.44
 a
 26.63 ± 4.33
 a
 286.96 ± 14.25
 d
 
Aqueous 47.46 ± 9.10
 b
 160.91 ± 12.54
 d
 589.14 ± 23.55
 e
 
Root    
Ethanol 6.83 ± 1.22
 a
 22.94 ± 5.22
 a
 24.86 ± 3.88
 b
 
Aqueous 10.54 ±  2.01
 a
                                          123.11 ± 10.99 c                             36.33 ± 4.11 c 
Standards    
Ascorbic acid 5.01 ± 0.76
 a
 64.65 ± 7.78
 b
 15.13 ± 3.22
 a
 
Gallic acid 5.62 ± 2.34
a
 6.30 ± 205.67
 e
* 41.68 ± 2.90
 c
 



















Ethanol extract    
Hydroquinone 10.71 86 110 
Resorcinol 10.83 99 110 
Vanillin 12.56 92 152 
n-Hexanoic acid 18.58 91 256 
Aqueous extract    
Catechol 10.12 95 110 
Resorcinol 11.25 97 110 
Pyrogallol 12.55 72 126 
Ethanol extract    
Hydroquinone 10.71 86 110 
 
Identified compounds of EtOH and aqueous extracts of different parts of C.cornifolia by GC-
MS, from all extracts of ethanol and aqueous aromatic compounds were identified are presented 



















Cissus cornifolia has been reported to have a variety of uses among which, the root decoction is 
used by traditional healers and herbalist to treat and manage a vast array of non-metabolic 
chronic disorders and ailments such as diarrhea and other stomach ailments, back pain, sore 
throat, wounds, diabetes and cardiac problems in the Mrewa district in Zimbabwe (personal 
communication with traditional healers). 
Preliminary investigations on the in vivo neuropharmacological activity of the methanolic 
leaf extract as well as its hypoglycemic activity on normoglycemic rats have been reported 
(Musa et al., 2008; Jimoh et al., 2013). Nevertheless, according to our current knowledge, there 
is no report on detailed anti-oxidative activities from any part of the plant or its phytochemistry.  
A set of in vitro assays were employed to cover most possible known mechanisms by which 
different antioxidants operate to inhibit oxidative chain reactions.  




 ), DPPH, 
hydroxyl radical and nitric oxide reducing ability)  indicated that all the different parts of C. 
cornifolia extracted in ethanol and water possess antioxidant potential in a concentration 
dependent manner to varying extents.  The ethanolic root extract has consistently shown to have 
exceptionally high antioxidant ability and the recorded high phenolics content (136.1 ± 10.6 
mg/g GAE), which supported the observed high activity and effectiveness of the extract in the in 
vitro assays. 
To identify the responsible phytochemicals, we carried out GC-MS analysis of the aqueous 
and ethanol extracts of the leaves and roots. Only long chain aliphatic compounds were 
identified in the ethanol and aqueous extract of the leaves. Palmitic acid, arachidic acid and 
nonacosane were identified by comparing their MS spectra to those of standard spectra from the 
NIST library. While no phytochemicals could be identified in the leaf extracts of the plant, the 
root extracts contained polyphenol compounds, known to be potent antioxidant compounds and 
is most likely responsible for the antioxidant activity in the root extract of the plant. Two isomers 
of benzenediol (hydroquinone and resorcinol) were found in the ethanol extract of the roots. 
It is highly probable that the polyphenols in the roots are the reason why the roots are more 
active as antioxidants than the leaves.  The mechanism by which these compounds act as radical 
scavengers is via the transfer of a hydrogen atom to a radical species, thereby creating a radical 
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charge on the polyphenol, which is delocalized on the aromatic ring stabilizing the radical charge 
(Fig. 4.3). The radical benzene molecule can be quenched by reacting with other radical species.   
In conclusion, the results of this study suggest that the ethanolic extracts of leaf and root have 
strong anti-oxidative effects which might be contributed by some major bioactive active 
compounds such as hydroquinone, resorcinol, vanillin and n-hexanoic acid. The anti-oxidative 
effects of the root ethanolic extract were better than the leaf ethanolic extract which can be used 
to investigate the in vivo anti-oxidative and anti-diabetic effects in the animal model of type 2 
diabetes. Additionally, findings of this study further support the use of the root and leaf extracts 
by traditional healers as an anti-diabetic medicine.  
 
4.1.7 Post-script analysis 
C. cornifolia extracts were further subjected to in vitro α-amylase, α-glucosidase inhibitory and 
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4.2.1 Preface 
This paper has not yet been submitted for publication. 
4.2.2 Abstract 
Hyperglycemia being the hallmark of type 2 diabetes mellitus, preventing it will go a long way 
in managing diabetes mellitus and its late complications. One therapeutical approach is by 
decreasing postprandial hyperglycemia this is achieved by retarding glucose absorption through 
inhibiting carbohydrates digesting enzymes (α-amylase and α-glucosidase). Cissus cornifolia 
extracts were investigated for α-amylase and α-glucosidase inhibitory activity in vitro. The root 
extracts (ethanol and aqueous) all had mild α-amylase inhibition activity and strong α-
glucosidase for ethanol root and aqueous root mild inhibition power also supported by IC50 
values (22.75 ± 1.23 and 33.70 ± 3.75 µg/ml) for α-amylase and (2.81 ± 0.97 and 37.48 ± 2.35 
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µg/ml) for  α-glucosidase. The ethanolic extracts shows to be relatively non-toxic at tested 
concentrations on the human embryonic kidney (HEK 293) cell lines as confirmed by the MTT 
assay. However aqueous extracts (leaf and root) were cytotoxic at concentrations above 50 
µg/ml. Data from this study suggest that the ethanolic extracts of roots of C. cornifolia possessed 
α-amylase, α-glucosidase inhibitory activity in vitro and did not cause significant cell death on 
the tested concentrations. The inhibition activity observed is strongly thought to be as a result of 
the identified polyphenols. The observed trend necessitates further investigations on the ethanol 
root extract in vivo. 
4.2.3 Introduction 
Diabetic cases have increased tremendously and expected to double in the next decade (IDF, 
2011; David et al., 2011), notably its occurrence in the developing countries where people have 
adopted high calorie westernized diets with lack of physical activities. Non-insulin-dependent 
diabetes mellitus (NIDDM) commonly referred to as type 2 diabetes contributes approximately 
90-95% of all diabetes cases (Wild et al., 2004). It is an endocrine system dysfunction caused by 
the diminished secretion of insulin by the pancreatic β-cells of the islets of Langerhans or by 
reduced sensitivity of cells to insulin action due to excessive absorption of glucose and failure to 
regulate blood glucose levels which leads to hyperglycemia (Iwamoto, 1995; Shaiq et al., 2002). 
Long-term diabetic complications have been strongly linked to hyperglycemia. Since the major 
source of glucose is dietary carbohydrates, hence the inhibition of key carbohydrates digesting 
enzymes such as α-amylase and α-glucosidase, would be vital in preventing late diabetic 
complications. This is because inhibitors of these enzymes (α-amylase and α-glucosidase) delays 
the digestion of carbohydrates, thereby prolongs the overall carbohydrate digestion time and 
reduces the rate of glucose absorption from the gut and finally, lowers the postprandial rise in 
blood glucose. Therefore, inhibition of α-amylase and α-glucosidase is a key in managing and 
treatment of noninsulin-dependent diabetes (Shaiq et al., 2002, Bischoff, 1994) 
Conventionally, the control of blood glucose level is achieved by using available oral 
hypoglycaemic agents and insulin all of synthetic origin, however all these have been reported to 
have limited efficacy and to pose undesirable side effects (Shaiq et al., 2002; Reuser and 
Wisselaar, 1994). Numerous plant-derived compounds which mimic the action of oral 
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hypogycaemic agents such as voglibose, miglitol and acarbose have been isolated (Yoshikawa et 
al., 1998; Nishioka et al., 1998,; Ortiz-Andrade et al., 2007; Shirwaikar et al., 2005) and prove 
to be effective in inhibiting carbohydrates digesting enzymes, hence more search of such plant-
derived compounds is required. Given that plant-derived products have shown impressing 
potentials such that they influence the discovery of some current conventional medicines being 
used at present (Shirwaikar et al., 2005). Unfortunately, some reports indicated the presence of 
some potential toxic and carcinogenic (Fennell et al., 2004) agents in some of these plants which 
makes them unsuitable for therapeutic applications. It is therefore of the utmost importance to 
intensively investigate the potential cytotoxic activity in order to validate the safety and 
continued use of medicinal plants. It has been documented that some plants extracts do have 
bioactivity however it is cancelled by their cytotoxicity, hence such scenarios need to be 
expansively evaluated to assess the overall efficacy of the plant extract, also to properly inform 
on how much of a certain plant extract is safe for therapeutical thereby avoiding overdosing and 
poisoning body organs. 
Cissus cornifolia (Baker) Planch (Vitaceae) commonly called the “Ivy grape” is indigenous to 
Zimbabwe. Locally, it is called ‘’Mudzambiringa’’ and ‘’Idebelebe’’ by the Shona and Ndebele-
speaking Zimbabweans respectively. The plant is traditionally used by the Shona speaking 
people as a remedy for gonorrhea when taken with native natron while the leaf-sap is used 
among the Tanganyika of Tanzania as a sedative in cases of mental derangement; the root-
decoction is also used for malaria, septic tonsil, diabetes, cardiac problems and pharyngitis 
(Burkill, 2000). Our survey of the medicinal use of C. cornifolia in Mrewa District, Zimbabwe 
also revealed that its roots are used to treat diabetes mellitus among other ailments (personal 
communications with traditional healers). 
Bioactivity and isolation of various compounds have been carried out in a number species from 
the genus Cissus and had shown impressive results. Cissus quadrangularis, Cissus sicyoides 
were explored and various phytoconstituents were identified which include: Vitamin C, β-
carotene, two asymmetric tetracyclic triterpenoids, β-sitosterol, α-amyrin, coumarin glycoside, 
coumarin sabandin, flavonoids, steroids, sitosterol and hydrolysable tannins (Attawish et al., 
2002; Ferreira et al., 2008). These compounds have been all report to play a major role in the 
medicinal value of these species (Ferreira et al., 2008). 
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At present, not much scientific information on C. cornifolia exists in the literature apart from 
preliminary reagent-based phytochemical analysis which revealed that the plant possesses 
glycoside, flavonoids, saponins, steroids, terpenoids, tannins (Jimoh et al., 2013; Musa et al., 
2008; Mariana et al., 2008; Jainu et al., 2006 and Varadarajan et al., 2008). According to the 
GC/MS results from our earlier study polyphenolic compounds such as pyrogallol, resorcinol 
and catechol, vanillin (aldehyde) and long chain fatty acids were identified as phytochemicals 
present and possibly responsible for the antioxidant activity observed.  
Polyphenols such as the ones we identified using GC/MS to be present in the extracts of 
C.cornifolia e.g. pyrogallol, resorcinol and catechol have not only been reported to possess 
antioxidant activities but the ability of inhibiting carbohydrate-hydrolyzing enzymes(α-amylase 
and α-glucosidase), henceforth can prevent hyperglycemia (Hanamura et al., 2005, Thilagam et 
al., 2013). However, despite the extensive use of these plant parts in traditional medicine, 
scientific reports on the biological and pharmacological actions of this plant are limited.  
The present study was therefore undertaken to intensively probe the antidiabetic and cytotoxicity 
activities of the C.cornifolia ethanol and aqueous root and leaf extracts as potential sources of 
nontoxic therapeutical agents which can be of use in achieving normoglycaemia, in order to 
avoid diabetes and its associated complications, using various scientific models in vitro. 
4.2.4 Materials and methods  
Please refer to the section 2.1 - 2.2 and 2.5 - 2.7 in pages (43 - 54) for detailed materials and 
methods. 
4.2.5 Results 
Fig. 4.5 shows the inhibitory activity of C.cornifolia ethanol and aqueous extracts on α-amylase 
and α-glucosidase respectively.  Fig. 4.5A is indicating the ability of ethanol and aqueous root 
extracts to have significantly higher (P<0.05) inhibitory activity on α-amylase than acarbose and 
all leaf (ethanol and aqueous) extracts do possess inhibition potential which is lower than that of 
the acarbose. Fig. 4.5B also indicated the ability of root extracts to have better inhibiting activity 
on α-glucosidase than acarbose. However the ethanol root extract inhibitory activity is 
significantly higher (P<0.05) than all other extracts and acarbose and that of the aqueous extract 
100 
 
is not significantly different from acarbose and all the leaf extracts (ethanol and aqueous) have 
lower activities than acarbose.  
  
 
Fig. 4.5: A and B = α-amylase and α-glucosidase respectively shows inhibitory activity of 
C.cornifolia aqueous and ethanol extracts. Arex= aqueous root extract and Erex= ethanol root extract; Alex= 
aqueous leaf extract and Elex= ethanol leaf extract. Data are presented as mean ± SD values of triplicate determinations. a-d 
Different superscripts letters for a given value within a column are significantly different from each other (Tukey’s-HSD multiple 










































































Table 4.7: IC50 values for α-amylase and α-glucosidase inhibition activity of C.cornifolia 
extracts 
 IC50 values in (μg/mL) 
Name of extract α-Amylase  α-Glucosidase  
Cc elex  90.78 ± 3.20 
c
 85.62 ± 5.54
 e
 
Cc alex 145.24 ±17.90 
d
 75.31 ± 9.34 
d
 
Cc erex 22.75 ±1.23
 a
 2.81 ± 0.97
 a
 
Cc arex 33.70 ± 3.75 
a
 37.48  ± 2.35 
b
 
Acarbose 52.11 ± 0.56
b
 57.18 ± 3.54
c
 
Data are presented as mean ± SD values of triplicate determinations. a-e Different superscripts letters for a given value within a 
column are significantly different from each other (Tukey’s-HSD multiple range post hoc test, P<0.05). Arex= aqueous root 




Fig. 4.6: Cytotoxicity activity C.cornifolia extracts on HEK 293 kidney cells lines as confirmed 
by MTT cell proliferation assay. Arex= aqueous root extract and Erex= ethanol root extract; Alex= aqueous leaf 
extract and Elex= ethanol leaf extract. Data are presented as mean ± SD values of triplicate determinations. a-c Different 
superscripts letters for a given value within a column are significantly different from each other (Tukey’s-HSD multiple range 
post hoc test, P<0.05). Arex= aqueous root extract and Erex= ethanol root extract; Alex= aqueous leaf extract and Elex= ethanol 
leaf extract 
The IC50 values of the root (ethanol and aqueous) extracts for inhibiting α-amylase and α-
glucosidase were significantly lower than acarbose and leaf (ethanol and aqueous) extracts. 
However, within the root (ethanol and aqueous) extracts, the ethanol extract had a more potent 
enzyme inhibitory activity than the aqueous extract (Table 4.7). Fig. 4.2 displays the cytotoxicity 
activity of C.cornifolia extracts on HEK 293 kidney cell lines as confirmed by MTT assay. As 
indicated in Fig. 4.6, C.cornifolia ethanol (leaf and root) extracts did not cause any significant 
decrease in cell viability across all tested concentrations (50 – 200 µg/ml). However, the aqueous 
(leaf and root) extracts displayed a notable increase in cell death as the concentration of extracts 
increases. This is also consistent with the high IC50 (Table 4.2) values obtained for C. cornifolia 
ethanol root and leaf extracts (2.67 ± 75.44 and 1.63 ± 120.11
 
mg/ml) respectively. All (leaf and 





































reduction in cell viability by approximately (50 and 30)% at 200 µg/ml respectively. The leaf 
extract is the most toxic as indicated by its lowest IC50 (Table 4.8) value of 241.29 µg/ml. 
Table 4.8: IC50 values for cytotoxicity activity of C.cornifolia extracts on HEK 293 kidney cells. 
Name of extract 
 
Cytotoxicity IC50 (μg/mL) 
 
CC elex 1.63 ± 120.11
 c
 * 
CC alex 241.29 ± 21.41
 a
 
CC erex 2.67 ± 75.44
 d
 * 
CC arex 726.67 ± 35.45
 b
 
Data are presented as mean ± SD values of triplicate determinations. a-d Different superscripts letters for a given value within a 
column are significantly different from each other (Tukey’s-HSD multiple range post hoc test, P<0.05). Arex= aqueous root 
extract and Erex= ethanol root extract; Alex= aqueous leaf extract and Elex= ethanol leaf extract 
4.2.6 Discussion  
One therapeutical approach for preventing diabetes mellitus is to retard absorption of glucose 
through inhibition of key carbohydrates digesting enzymes, α-amylase and α-glucosidase, which 
are located in the brush borders of the small intestines. Currently, drugs that act by this 
mechanism include acarbose, miglitol and voglibose (Shaiq et al., 2002). Numerous reports 
indicates a variety of compounds which had been extracted from medicinal plants possess this 
ability (Yoshikawa et al., 1998; Nishioka et al., 1998; Ortiz-Andrade et al., 2007; Shirwaikar et 
al., 2005), however, for the first time this study observed the α-amylase and α-glucosidase 
inhibitory potential of C. cornifolia, a plant commonly used for traditional treatment of diabetes 
in Zimbabwe. 
The present study showed that C.cornifolia root (ethanol and aqueous) extracts moderately 
inhibits α-amylase and ethanol root extract significantly inhibit α-glucosidase whilst the aqueous 
root extract also moderately inhibits α-glucosidase as evidently shown by the IC50 in Table 4.8. 
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According to Krentz and Baile, (2005), better clinical outcome could be derived from specific α-
amylase and α-glucosidase inhibitors with a mild inhibitory activity against the α-amylase and 
strongly inhibiting  α-glucosidase and also not cytotoxic to target cells, but still achieving the 
desired result of delaying postprandial hyperglycemia are ideal potent anti-hyperglycemic 
compound(s) or drug.  
In the present study, C.cornifolia leaf extracts to have no significant enzyme inhibition potential. 
However the root extracts showed inhibition which is greater than acarbose for ethanol root 
extract however for aqueous extract data are not significantly different from acarbose. We 
reported earlier the phytoconstituents of C.cornifolia root extracts to be mainly polyphenols 
which include isomers of benzenediol (resorcinol, catechol and hydroquinone), pyrogallol and 
vanillin (phenolic aldehyde). These compounds are possibly the bioactive components of the 
extracts. Apart from being effective antioxidants, phenolic compounds and phenol derivatives, 
have been reported to be potent α-glucosidase and α-amylase inhibitors in some previous and 
recent studies (de Sousa et al., 2004, Hanamura et al., 2005, Thilagam et al., 2013). So the 
observed inhibitory activity of the root extracts might be caused by the identified phenolics 
unlike the leaf extracts, where only long chain aliphatic compounds were identified and no 
significant inhibitory activity was observed. Thus, based on these results we postulated that the 
observed inhibitory activity of the C. cornifolia ethanolic extract is due to one or more different 
compounds, especially the phenolics, present in the extracts.  
We investigated the cytotoxicity of C.cornifolia extracts and we also found out that ethanol 
extracts did not cause any significant decrease in cell viability however there was notable 
decrease of viability with aqueous extracts (leaf and root). There were no previous reports on the 
cytotoxicity activity of C.cornifolia. The observed decrease in cell viability is due to HEK 293 
cell death; hence, C.cornifolia aqueous extracts are cytotoxic at a concentration of 50 µg/ml. 
Therefore, it necessitates further investigation of C.cornifolia extracts to identify the responsible 
compounds for the observed toxic activity and further assess their chemotherapeutical properties.  
The root (ethanol and aqueous) extracts displayed an impressive enzyme inhibition potential as 
compared to the leaf (ethanol and aqueous) extracts, however the aqueous extracts (leaf and root) 
caused a significant decrease in cell viability. The aqueous extract shows high enzyme (α-
amylase and α-glucosidase) inhibition potential however it is cancelled by the toxic effects it 
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displayed. So within the root (ethanol and aqueous) extracts the ethanol root extract indicates to 
be a better anti-hyperglycemic agent. This result could stimulate further investigation of ethanol 
root extracts in vivo.  
Based on the results presented in this study, it can be concluded that ethanolic root extract of 
C.cornifolia exerts an inhibitory effect on α-glucosidase and α-amylase and also shows to be 
relatively non-toxic at tested concentrations. Furthermore, the results displayed by the ethanol 
root extract are interesting enough to be used in in vivo models.  These results additionally back 
the traditional use of plants in medicine based on in part, their antioxidant activity and also 
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5.1.1 Preface: 
This section of the thesis is still under preparation into a manuscript to be published shortly. 
5.1.2 Abstract 
The compounds isolated from plant extracts have been reported to have different mechanisms of 
action behind their anti-diabetic effects both in vivo and in vitro. Extracts which show one or 
more of these mechanisms will be valuable for therapeutical applications. In this experiment, 
such mechanisms were investigated in Courbonia glauca ethanol and aqueous extracts. The anti-
oxidative activities of the ethanol and aqueous extracts of the leaf and root samples of C.glauca 
were determined across a series of four in vitro models. The results showed that all the extracts 
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), DPPH, hydroxyl and nitric oxide radical scavenging abilities. 
The ethanol root extract had more potent antioxidant power in all the experimental models and 
do possess a higher total phenol content of 94.4±7.9 mg/g. The leaf and root ethanol extracts  of 
C.glauca was found to possess α-glucosidase inhibitory activity and only the ethanol leaf extract 
was able to significantly inhibit α-amylase activity. The cytotoxicity of all four extracts of  C. 
glauca were also evaluated in HEK293 cell lines. None of the extracts showed significant 
cytotoxicity in the tested concentration range except for the C. glauca aqueous leaf extract which 
was highly toxic as displayed by its low IC50 value of 170.76 µg/ml. Hence three of the extracts 
are safe for pharmaceutical applications. The GC-MS analysis of the aqueous and ethanol 
extracts of the roots and leaves indicated that several aromatic phenolic compounds, present in 
these extracts, could possibly be responsible for the observed activities.  
5.1.3 Introduction 
Diabetes mellitus (DM) is considered as a metabolic disease characterized by hyperglycemia 
resulting from defects in insulin secretion, insulin action, or both (Alberti and Zimmet, 1998). It 
is a chronic disorder associated with micro- and macrovascular complications and long-term 
degenerative complications which results in dysfunction of various organs (Lacy and Davie, 
1984). The disease is a major health concern globally because it is estimated to affect 285 
million people around the world by 2010, with a projected rise to 552 million by 2030 (Gardner 
et al., 2011). 
Out of all the known types of DM, type 2 diabetes (T2D) accounts for approximately 90-95% of 
all diabetic cases, which is a result of genetic predisposition, life-style and socioeconomic 
changes mainly characterized by a decrease of physical activity and an increase in high fat intake 
among other factors (Kriska et al., 1993; Dowse et al., 1991; Boyce and Swinburn, 1993; Wild et 
al., 2004; IDF Atlas, 5th edition, 2011, Gardner et al., 2011). Hyperglycemia is a hallmark of 
T2D and has been reported to cause oxidative stress through multiple mechanisms. Compelling 
evidence had demonstrated the key role played by hyperglycemia in the initiation and the 
facilitation of oxidative stress (OS) (Nishikawa et al., 2000; Calabrese et al., 2012). 
Hyperglycemia increased the production of intracellular reactive oxygen species (ROS) through 
the activation of protein kinase C, generation of advanced glycation end products (AGEs) and 
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activation of sorbitol pathway which plays a key role in the pathogenesis of diabetic 
complications (Brownlee, 2000 and 2001; Calabrese et al., 2012).  
Hence, the devastating effects of hyperglycemia and the resulting OS have compelled the 
scientific community to search for anti-hyperglycemic and anti-oxidative compounds which can 
counteract these effects.  This will consequently be vital in the therapy and prevention of T2D 
(Wright et al., 2006). One of the most important approaches for the control of hyperglycemia is 
through the use of α-amylase and α-glucosidase inhibitors (Shirwaikar et al., 2005). Inhibition of 
these key carbohydrates digesting enzymes will ensure a decrease in the postprandial rise in 
blood glucose level by delaying the digestion of carbohydrates, thereby prolonging the overall 
carbohydrate digestion time and reducing the rate at which glucose is absorbed from the gut. 
Thus, inhibition of α-amylase and α-glucosidase is key in the management and treatment of T2D 
and the prevention of diabetic complications (Shaiq et al., 2002, Bischoff, 1994). Based on the 
above, the identification of a multifunctional compound(s) that acts as an antioxidant and anti-
hyperglycemic agent will go a long way in curbing diabetes and its related complications. Such a 
compound will reduce the costs of synthesizing separate compounds that work on specific 
mechanism of action. Currently, there are several conventional prescribed α-glucosidase 
inhibitor drugs which include acarbose, voglibose and miglitol; however, they have been shown 
to have some undesirable adverse effects such as flatulence, diarrhea and abdominal pain which 
were hostile to patients (Shaiq et al., 2002). This indicates the urgent need for the development 
of newer alternatives. 
Medicinal plants have a long history of being used to treat various ailments and diseases. Some 
of these plants and plant derived products have influenced the discovery of some current 
conventional medicines. For example, metformin is an analog of galegine which was extracted 
from Galega offinalis (Jarald et al., 2008; Patel, 2012). The use of plants for medicinal purposes 
still exists in the developing nations, especially in Africa where a wide variety of plants were 
reported to have many medicinal uses (van Wyk, 2008; Ibrahim et al., 2013). This has motivated 
researchers to keep on working on medicinal plants in order to identify and/or isolate useful 
bioactive compounds from medicinal plants (Musa et al., 2011). Despite the extensive use of 
plants in alternative medicine, some reports indicated the presence of potentially toxic and 
carcinogenic agents in some plants, which make them unsuitable for therapeutic applications 
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(Fennell et al., 2004). It is therefore of the utmost importance to intensively investigate the 
potential cytotoxicity of the plant in order to validate safety for their continued use. It has been 
documented that although some plant extracts have bioactivity, this is counteracted by their 
cytotoxicity beyond certain concentration ranges, hence such scenarios need to be evaluated to 
assess the overall efficacy of the plants (Fennell et al., 2004). 
Courbonia glauca (Klotzsch) Gilg & Bened (Capparaceae) is commonly called the Blue bush-
cherry (English), Katunguru (Shona: Zimbabwe) and Muswezu or Soswe (Tonga: Zimbabwe) 
(Hyde et al., 2013). According to a verbal communication survey we conducted in Mrewa and 
Mutoko districts in Zimbabwe in 2012, the root and leaves of. C. glauca were reported to be used 
to treat cancer, bacterial infections, hypertension and DM as well as wound healing. However, 
despite the extensive use of these plant parts in traditional medicine, scientific reports on the 
biological and pharmacological actions of this plant are limited. 
The present study was therefore undertaken to intensively probe the antioxidant activities, α-
amylase and α-glucosidase inhibitory effects and cytotoxicity of extracts from the root and leaves 
of C. glauca.   
5.1.4 Materials and methods  
Please refer to the section 2.1 – 2.7 in pages (43 - 54) for detailed materials and methods. 
5.1.5 Results 
A higher percentage recovery was recorded in the aqueous extracts but the total phenolic content 
was significantly (P<0.05) higher in ethanol extracts with ethanol root extract of C.glauca having 







Table 5.1: Percentage recovery (g/g) and total phenolics content of various solvent extracts of 
C.glauca parts 
Data are presented as mean ± SD values of triplicate determinations. a-c Different superscript letters for a given value within a 
column are significantly different from each other (Tukey’s-HSD multiple range post hoc test, P<0.05) 





indicated by the concentration dependent increase in the percentage reducing power (Table 5.2). 
However, the ethanol and aqueous extracts of the roots have a higher reducing potential than the 








Samples % recovery (g/g) Total polyphenol (mg/g GAE) 
Leaves   
EtOH 2.1 80.1 ± 4.9
b
 
Aqueous 7.7 64.0 ± 6.4
a
 
Root   
EtOH 1.4 94.4 ± 7.9
c
 











15  30 60 120 240 
Leaves      
EtOH 14.17 ±1.30
a









Aqueous 11.21 ± 3.39
a
 16.03 ± 4.54
a
 28.12 ± 0.88
a





Root      
EtOH 24.41 ± 1.12
b
 38.55 ± 2.66
b
 41.40 ± 0.45
b
 57.93 ± 2.39
b
 68.24 ± 1.05
b
 
Aqueous 18.06 ± 2.02
a
 28.38 ± 0.20
b
 44.60 ± 0.63
b
 53.13 ± 1.80
b
 62.84 ± 1.10
b
 
Standard      
Ascorbic acid 76.83 ± 4.92
c
 80.24 ± 3.00
c
 90.26 ± 5.51
c
 91.08 ± 5.43
c
 93.60 ± 6.21
c
 
Data are presented as mean ± SD values of triplicate determinations. a-c Different superscript letters for a given value within a 
column are significantly different from each other (Tukey’s-HSD multiple range post hoc test, P<0.05) 
Fig. 5.1A and 5.1B showing the free radical scavenging activities of the ethanol and aqueous 
extracts of C. glauca roots and leaves clearly indicates the ability of all the extracts to scavenge 
free radicals proportional to the concentration. The high activity of both the aqueous and ethanol 






Figure 5.1A and 5.1B: DPPH radical scavenging activity of aqueous and ethanol extracts of 
C.glauca leaf and root respectively. Alex= aqueous leaf extract; Elex= ethanol leaf extract; Arex= aqueous root 
extract; Erex= ethanol root extract. Data are presented as mean ± SD of triplicate determinations. a-cValues with different letters 
over the bars for a given concentration of each extract are significantly different from each other (Tukey’s-HSD multiple range 
post hoc test, P<0.05). 
 
As indicated in Tables 5.3 and 5.4, the ethanol (leaf and root) extracts displayed significantly 
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compared to the aqueous extracts and the two standards (gallic acid and abscorbic acid). IC50 
values in Table 5.5 also further emphasize the better anti-oxidant activity posed by the ethanol 
root extract because it had the lowest IC50 value across all tested in vitro models. 





 Concentration (µg/ml) 
15 30 60 120 240 




 31.60 ± 2.1
c
 46.11 ± 1.6
d
 60.82 ± 1.8
d




7.40  ± 3.7
a
 7.80 ± 0.6
a
 11.72 ± 2.3
a
 20.13 ± 2.0
a
 33.41 ± 0.7
a
 

























Standards      
Ascorbic 
acid 
14.50  ± 2.20
a
 17.35 ± 3.10
a 
 21.85 ± 0.10
a
 26.80 ± 0.70
a 












 40.20 ± 0.20
a
 
Data are presented as mean ± SD values of triplicate determinations. a-dDifferent superscript letters for a given value within a 







Table 5.4: Percentage NO scavenging activities of extracts from various parts C.glauca 
 
Extracts 
  Concentration (µg/ml) 
15 30 60 120 240 




 31.8 ± 2.9
b








ND 2.6 ± 0.1
a
 13.27 ± 0.6
b
 24.12 ± 0.1
b








 35.87 ± 1.5
c
 41.29 ± 0.8
c
 63.15 ± 1.6
c




ND 11.73 ± 0.3
a
 23.9 ± 0.5
b
 28.22 ± 0.5
b
 36.91 ± 0.5
b
 
Standards      
Ascorbic acid 51.44 ± 0.05
c
 56.94 ± 0.90
c 
 58.37 ± 1.40
c 
 62.44 ± 0.70
c
 77.22 ± 1.20
c
 
Gallic acid 43.06 ± 9.20
b
 47.36 ± 0.70
c
 49.76 ± 0.70
b 
 59.33 ± 3.20
c
 64.59 ± 6.20
c
 
Data are presented as mean ± SD values of triplicate determinations. a-dDifferent superscripts letters for a given value within a 








Table 5.5: IC50 values of various solvent extracts of C.glauca parts in different in vitro models 
IC 50 values in µg/ml 
Samples  DPPH HRS NO   
Leaves    
Ethanol 16.26 ±1.23
 b
 22.53 ± 4.53
 a
 174.16 ± 23.24
 e
 
Aqueous 79.45 ± 6.55
 d
 285.50 ± 12.76
 d
 544.51 ± 31.98
 f
 
Root    
Ethanol 14.36 ± 2.11
 b
 21.36 ± 2.78
 a
 7.69 ± 1.05
 a
 
Aqueous 31.18 ± 4.32
 c
   102.51 ± 8.97
 c
                     123.33 ± 14.17
 d
 
Standards    
Ascorbic acid 5.01 ± 0.76
 a
 64.65 ± 7.78
 b
 15.13 ± 3.22
 b
 
Gallic acid 5.62 ± 2.34
a
 6.30 ± 205.67
 e
* 41.68 ± 2.90
 c
 
The * represent the units of these values which are in mg/ml. Data are presented as mean ± SD values of triplicate 
determinations. a-fDifferent superscripts letters for a given value within a column are significantly different from each other 
(Tukey’s-HSD multiple range post hoc test, P<0.05). 
We also investigated the inhibition activity of C. glauca ethanol and aqueous extracts on α-
amylase and α-glucosidase. Fig. 5.2 and 5.3 shows the inhibitory activities of C. glauca extracts 
on α-amylase and α-glucosidase respectively. In Fig. 5.2, the ethanol leaf extract was found to 
have a better α-amylase inhibition activity with an IC50 of 50.25±1.23μg/mL (Table 5.6).  In Fig. 
5.3, the ethanol leaf and root extracts were shown to have better α-glucosidase inhibition 
activities with IC50 values of 35.85±5.21 μg/mL and 42.34±1.23 μg/mL respectively (Table 5.6), 






 Fig. 5.2 and 5.3: α-amylase and α-glucosidase inhibitory activity of C.glauca aqueous and 
ethanol extracts respectively. Alex= aqueous leaf extract; Elex= ethanol leaf extract; Arex= aqueous root extract; 
Erex= ethanol root extract. Data are presented as mean ± SD values of triplicate determinations. a-dDifferent superscripts letters 
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Table 5.6: IC50 values for α-amylase and α-glucosidase inhibition activity of C.glauca extracts. 
 IC50 values in (μg/mL) 
Name of extract α-Amylase  α-Glucosidase  
Cg elex 50.27 ± 1.23
a
 35.82 ± 5.21
a
 
Cg alex 252.20 ± 2.11
c
 68.68 ± 3.21
b
 
Cg erex 109.16 ± 4.01
b
 42.34 ± 1.23
a
 
Cg arex 368.53 ± 2.82
d
 90.18 ± 4.32
c
 
Acarbose 52.11 ± 0.56
a
 57.18 ± 3.54
b
 
Data are presented as mean ± SD values of triplicate determinations. Alex= aqueous leaf extract; Elex= ethanol leaf extract; 
Arex= aqueous root extract; Erex= ethanol root extract.  a-dDifferent superscripts letters for a given value within a column are 
significantly different from each other (Tukey’s-HSD multiple range post hoc test, P<0.05). 
Fig 5.4 shows the cytotoxicity activity of the C.glauca extracts on HEK 293 kidney cell lines as 
confirmed by the MTT assay. The C. glauca ethanol root and leaf and the aqueous root extract 
did not show any significant decrease in cell viability across all tested concentrations (50 – 200 
µg/ml). This is also consistent with the high IC50 (Table 5.5) values obtained for C. glauca 
ethanol root and leaf and the aqueous root extracts which are 3.22 mg/ml, 3.52 mg/ml and 822.45 
µg/ml respectively. However, C.glauca aqueous leaf extract was shown to be toxic because it 
significantly decreased the viability of cells down to approximately below 50% at 200 µg/ml and 
also had significantly lower IC50 values (Table 5.4) with a value of 170.76 µg/ml compared to the 




Fig. 5.4: Cytotoxicity activity C.glauca extracts on HEK 293 kidney cells lines as confirmed by 
MTT cell proliferation assay. Alex= aqueous leaf extract; Elex= ethanol leaf extract; Arex= aqueous root extract; 
Erex= ethanol root extract. Data are presented as mean ± SD values of triplicate determinations. a-dDifferent superscripts letters 
for a given value within a column are significantly different from each other (Tukey’s-HSD multiple range post hoc test, P<0.05). 
Table 5.7: IC50 values for cytotoxicity activity of C.glauca extracts on HEK 293 kidney cells. 
 
The * represent the units of these values which are in mg/ml. Data are presented as mean ± SD values of triplicate 
determinations. a-dDifferent superscripts letters for a given value within a column are significantly different from each other 
(Tukey’s-HSD multiple range post hoc test, P<0.05). 
The ethanol and aqueous extracts of the roots and the leaves were subjected to GCMS analysis in 
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Name of extract Cytotoxicity IC50 (μg/mL) 
Cg elex 3.52 ± 0.23
a *
 
Cg alex 170.76 ± 12.11
c
 
Cg erex 3.22 ± 0.14
b *
 





contained in the NIST library.  The results indicated the presence of the dihydroxy phenols; 
resorcinol, catechol and hydroquinone and methoxylated phenols, 2-methoxyphenol and 3,4-
dimethoxyphenol as well as an aromatic ester, methyl benzoate, a derivative of benzoic acid, 
which is a known preservative (Table 5.8; Fig. 5.5).   
Table 5.8: Compounds identified by GC-MS from the EtOH and aqueous extracts of the leaves 
and roots of C.glauca  
 







Ethanol root extract    
catechol 10.56 76 110 
Resorcinol 11.76 89 110 
Hydroquinone 11.78 81 110 
Ethanol leaf extract    
2-methoxyphenol 
(guaiacol) 
8.21 82 124 
Resorcinol 14.39 72 110 
Aqueous root extract    
2-methoxyphenol 
(guaiacol) 
8.87 85 124 
Methyl benzoate 8.89 87 136 
Catechol  10.43 91 110 



























methyl benzoate  
Fig. 5.5: Compounds identified by GCMS in the various extracts of C. glauca leaves and roots 
with their mass to charge ratios indicated for each compound as detected by the GCMS 
instrument. 
5.1.6 Discussion 
Courbonia glauca is used by traditional healers to treat and manage non-metabolic chronic 
disorders in Mrewa district Zimbabwe.  In this study, we determined the anti-oxidative as well as 
α-amylase and α-glucosidase inhibitory activities of the ethanol and aqueous extracts from the 
leaves and roots in the hope of finding a lead in the search for extracts with potential compounds 
that could be useful in retarding postprandial hyperglycemia and oxidative stress-associated 
complications in type 2 diabetes.  
The significantly (P<0.05) higher antioxidant ability of the ethanol extract of the root indicate 
that the phytochemical components with high redox potential in these plant parts are more 
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soluble in ethanol than water.  As indicated by Hinnerburg et al., (2006), the degree of the free 
radical reduction is reflective of the radical scavenging (antioxidant) power of the compound. 
The results of the DPPH assay of the aqueous and ethanol extracts of the leaves and roots 
revealed that virtually all extracts possessed stronger free radical scavenging potential compared 
to gallic and ascorbic acids. Notably were the ethanol extracts which indicated to have a 
significantly high ability to scavenge free radicals at 240 µg/ml which was not significantly 
(P<0.05) different from gallic and ascorbic acids.  
As indicated in Tables 5.3 and 5.4, the ethanol extracts of the leaf and root have significantly 
high NO and hydroxyl radical scavenging ability which was concentration dependent as 
compared to the aqueous extracts and the two standards (gallic acid and abscorbic acid). Table 
5.5 also indicated that the ethanol root extract showed IC50 values which were lower than the 
standards used and hence had better antioxidant potential across all tested in vitro models. This 
observed difference between extracts can be linked to the way in which the nitric oxide and 
hydroxyl radicals are generated and the different physical and chemical properties of the 
antioxidants contained in the extracts (Schwarz et al., 2001). 
The present study showed that the C. glauca ethanolic leaf extract moderately inhibits α-amylase 
and α-glucosidase to a significant extent as evidently shown by the IC50 values (Table 5.6). This 
properly supports an effective T2DM management because it was shown to be a strong inhibitor 
of intestinal α-glucosidases and a mild inhibitor of pancreatic α-amylase (Krentz and Baile, 
2005). To the best of our knowledge, we did not find any prior reports on the antidiabetic 
(specifically α-amylase and α-glucosidase inhibition) activity of this plant. The ethanolic leaf 
extracts shows to have both α-amylase and α-glucosidase inhibitory activity however it strongly 
inhibits α-glucosidase, whereas the ethanolic root extract showed a mild α-glucosidase inhibition 
activity. α-Amylase and α-glucosidase could potentially be applied as an effective approach in 
post prandial hyperglycemia management in diabetes type 2 therapy.  
Fannell et al. (2004) reported that despite widespread use of plants in medicine, they are also 
potentially toxic at certain concentration ranges and hence some plants are unsuitable for 
therapeutical applications. A literature search revealed that no prior work was done on the 
cytotoxicity of C. glauca and no toxicity was reported throughout its use in treating a variety of 
ailments. In this study, the HEK 293 kidney cell lines were used to investigate the cytotoxicity of 
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C.glauca and it was confirmed by using the MTT cell proliferation assay. This technique is 
based on the ability of succinate dehydrogenase enzymes present in the mitochondria of viable 
cells to reduce the yellow water soluble substrate MTT into an insoluble, purple formazan 
product that is further dissolved with the use of DMSO solution. Since this process may occur 
only in viable, metabolically active cells, the level of activity is the measure of viability. C. 
glauca ethanol root and leaf extracts and the aqueous root extract did not show any significant 
decrease in cell viability across all tested concentrations (50 – 200 µg/ml). This indicated that the 
concentration range tested for these plant parts is safe at least in an in vitro model and also 
proved to have significant activities across a set of antioxidant and enzyme inhibition models. 
However, the aqueous leaf extract displayed cytotoxicity at all tested concentration and hence is 
not recommended for therapeutical applications at any concentration approximately ≥50 µg/ml. 
The identification of the dihydroxyphenols and the methoxyphenols in both ethanol extracts and 
the aqueous root extracts further support the notion that these extracts have the potential to be 
used as antioxidants as these compounds are capable of donating a hydrogen atom to a radical 
species and quenching them. The generated oxygenated radical of the aromatic species has the 
ability to be delocalized on the molecule which renders them more stable than other radical 
generated species, hence their ability to act as antioxidants.  The ethanol root extract was seen to 
have three such compounds, resorcinol, catechol and hydroquinone (Fig 5.5) and therefore from 
a chemical point of view, this extract was seen to have more antioxidant potential than the other 
extracts. Phenolics have been reported to be potent α-glucosidase and α-amylase inhibitors in 
some previous and recent studies (de Sousa et al., 2004, Hanamura et al., 2005, Thilagam et al., 
2013). So the observed inhibitory activity of the extracts might be caused by the identified 
phenolics. 
This study provided data to support the use of C. glauca roots as an antidiabetic agent that could 
be used by traditional healers in Zimbabwe. All the extracts displayed an impressive ability to 
inhibit key carbohydrate digesting enzymes. Normally, the aqueous extract is what is used to for 
medicine; however the ethanol extract has indicated significantly better activity and to be safer 
than the aqueous extract. Further phytochemical and pharmacological studies will be required to 
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6.1.1 General Discussion  
The global health burden posed by diabetes mellitus is tremendously increased at an alarming 
rate and ultimately motivated the search for better treatment options. Diabetes mellitus (DM) has 
turn out to be one of the worst killer disease globally, it’s being projected to be the 7th worst 
killer diseases by 2030 (WHO, 2011). Its high prevalence has also overburdened a lot of 
economies due to the high costs of treatments of its associated late complications. Also in the 
light of the fact that the current treatment options have lots of side effects which come along with 
their prolonged usage due to their synthetic nature. This and other factors have called for a need 
to explore other options specifically of natural origin, basing on the fact medicinal plants have 
been in use especially in developing nations for ages and also to a significant extent had 
influenced the discovery of most modern day therapeutical compounds and also few side effects 
have been reported from their use. 
Hyperglycemia is the hallmark of T2D mellitus (most prevalent form of diabetes mellitus), 
targeting any of its pathogenic pathways will go a long way in preventing the disease and its late 
complications. Hyperglycemia has also been the major cause of oxidative stress (OS), the 
combination of these two conditions has been reported to be major biological players for the 
pathogenesis of T2D. In this study, we investigated the various antioxidant and anti-
hyperglycemic activities of crude extracts of three Zimbabwean plants (A.antunesiana, 
C.cornifolia and C.glauca) using various in vitro model and also elucidated their safety. 
In our study, we observed that all the antioxidant activities were to a greater extent linked to the 
total polyphenolic content. The higher the total polyphenol content of an extract, the more potent 
was its antioxidant power. This can be explained by the nature of polyphenols which have the 
ability to donate a hydroxyl group or electron that will react and neutralise the free radical, hence 
termed radical scavengers. In all three plants, crude extracts had much pronounced activity and 
we significantly noticed in the roots extracted with ethanol which suggests that possibly the most 
bioactive compound(s) of these Zimbabwe-harvested plants is much prevalent in this part of the 
plants and also much more soluble in ethanol than water. Based on this observation, we 
recommend that it is more effective to use ethanol in extracting phytoconstituents from these 
plants in order to maximize therapeutical benefits of these medicinal plants.  
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Albizia antunesiana recorded highest polyphenolic content also consistently show higher 
antioxidant power across all models used. A number of benzene related polyphenols; coumarin 
and triterpenoids were identified in this plant and notably were its highest activity in the ethanol 
root part (Table 3.6). Apart from the ability to scavenge free radicals, we also investigated the 
inhibition of carbohydrates digesting enzymes such as α-amylase and α-glucosidase and all the 
extracts show the ability to inhibit these enzymes to varying extents and notably is the fact that 
the enzyme inhibitory activities was directly proportional to the total phenol content (Table 3.1; 
Fig. 3.5) . The identified polyphenols have been reported to be also effective α-glucosidase and 
α-amylase inhibitors. Albizia antunesiana have shown to have better antioxidant potential than 
the rest of the plants hence a better source of antioxidant compounds and furthermore it did not 
have a significant cytotoxicity activity. 
Cissus cornifolia also recorded same trend as Albizia antunesiana as an impressive anti-diabetic 
agent source through free radical scavenging and inhibition of carbohydrates digesting enzymes. 
The ethanol root extract displayed a consistently high activity across all antioxidant models 
which are probably due to the high polyphenol content observed (Table 4.1; Table 4.5). We 
linked the observed activities to the identified compounds which include benzenediol (resorcinol, 
catechol and hydroquinone), pyrogallol and vanillin a phenolic aldehyde. These compounds are 
possibly the bioactive components of the extracts hence the higher antioxidant activities 
observed (Table 4.1; Table 4.5; Table 4.6). The ethanol root extract apart from being the better 
antidiabetic it also displayed to not cause significant decrease in cell viability hence it safer for 
therapeutical application at least in vitro.  Cissus cornifolia extracts overally show to be 
intermediate antidiabetic agent source.  
Courbonia glauca antidiabetic potential also followed the same trend with A.antunesiana and 
C.cornifolia. The ethanol extracts were better antioxidants and anti-hyperglycemic agents than 
aqueous extracts and this was due the higher polyphenols extract in ethanol extracts. These 
compounds are well known to be good radical scavengers and also α-glucosidase and α-amylase 
inhibitor (de Sousa et al., 2004, Hanamura et al., 2005, Thilagam et al., 2013). The ethanol 
extracts displayed the least cytotoxicity activity on Human Embryonic Kidney cell lines (HEK 
293) as compared to aqueous extracts (Fig. 4.6; Table 4.7). However despite all the anti-diabetic 
activity by extract of Courbonia glauca,  they were the least active extracts of the three tested 
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plants and this is also confirmed with lowest total polyphenol content of the three 
(A.antunesiana, C.cornifolia and C.glauca). This further confirms our earlier assertions that most 
of the biological activities measured, at least for the plants under study are mediated by 
polyphenolics. Hence, phenolics from these plants could serve as antidiabetic agents.  
The observed trends in the data presented for the three plants can further be substantiated by the 
nature of phytoconstituents observed in the extracts of these plants by GC-MS. The antioxidant 
activities recorded might have been mediated at least in part through the donation of OH
- 
group 
and accepting of electrons which will result in neutralization of the resultant radical(s). In 
A.antunesiana we detected isomers of benzene diol, benzene triol, coumarins double ringed, and 
multiple benzene ringed tripernoids such as amyrin. This indicates the presence of compounds 
with a lot of free hydroxyl groups hence better capacity to quench radical(s). In extracts of 
C.cornifolia we detected isomers of benzene diol, benzene triol and vanillin (phenol aldehyde), 
which also have a moderate ability to quench radicals however not as much as A.antunesianna 
extracts. In C. glauca extracts we detected isomers of benzene diol and a variety phenolic 
compounds conjugated to other group e.g. methyl and mainly there were only having single OH
- 
group available hence the least radical scavenging ability of the three. Since the enzyme 
inhibition ability has been reported to be strongly linked to the phenolic content  the plant (Table 
5.1; Fig. 5.2; Fig. 5.3; Table 5.6). Hence better extracts in terms of antioxidant and anti-
hyperglycemic power were from A.antunesianna followed by C.cornifolia and the least were 
from C. glauca, regardless of these difference some extracts from these plants specifically the 
ethanol root parts showed encouraging results which warrants further investigations. Aqueous 
extracts were the more toxic of the two solvents used hence not encouraged for therapeutic 
applications. 
Our data show that all extracts from different plants we investigated followed a general trend 
wereby the aqueous extracts caused much decrease in cell viability than ethanol extracts.  Also 
the ethanol root extracts did not caused much cell death as observed in leaf extracts and overally 
the Albizia antunesiana cause the least cell death. Looking at the observed trends it clearly 
indicates that the bioactive components were mostly extracted from the roots part and the least 
activity and much cytotoxicity was witnessed with leaf extracts. The given data also supports the 
use of the root part of the plants for medicinal purposes which might be all based on the high 
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polyphenolic content of these parts among other bio-components. However, the observed trends 
are impressive enough to take the extracts which displayed high activities for further analysis in 
vivo.  
However, results obtained in vitro might tend to differ from in vivo assays since there are a lot of 
factors that plays various and significant interfering roles under in vivo conditions. Hence, in 
order to completely conclude on the bioactivity of compounds both in vitro and in vivo results 
need to agree. Thus, further investigation need to be done using in vivo models in order to verify 
if the observed activities will be maintained inside a living system  
6.1.2 Conclusion 
Our results on the three plant species (A.antunesiana, C.cornifolia and C.glauca) used in the 
traditional medicine of Mrewa showed that all three species possess remarkable anti-diabetic 
activity which is mediated, at least in part, through free radical scavenging and α-amylase and α-
glucosidase inhibition mechanisms of action.  In particular, A.antunesiana ethanol root extract 
showed the highest activity compared to that of other extracts. We strongly believe the high 
antioxidant capacity observed to be related, to the polyphenolics found in this extract. Our data 
strongly support the use of the three medicinal plants to treat diabetes as they have displayed to 
have significant antioxidant and anti-hyperglycemic activities. 
6.1.3 Recommendations 
Further investigation on these plant parts for in vivo antidiabetic activity is highly encouraging. 
We recommend more investigations using partitioned fractions of these plants extracts in order 
to identify the most active compound(s). Furthermore, the use other specific isolation techniques 
is encouraged  so as to isolate the probable active compound(s) and individually characterize 
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Fig. AA01:  GC-MS chromatogram of A.antunesiana aqueous leaf extract 
 




Fig. AA03 GC-MS chromatogram of A.antunesiana ethanol leaf extract. 
 





Fig. CC01: GC-MS chromatogram of C.cornifolia aqueous leaf extract. 
 





Fig. CC03: GC-MS chromatogram of C.cornifolia ethanol leaf extract. 
 






Fig. CG01: GC-MS chromatogram of C.glauca aqueous root extract 
 
Fig. CG02: GC-MS chromatogram of C.glauca ethanol root extract 
 
